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ABSTRACT 
 
STUDY OF THE EFFECTS OF SILVER IONS AND SILVER NANOPARTICLES ON 
EMBRYONIC DEVELOPMENT 
 
Martha Sharisha Johnson 
Old Dominion University, 2019 
Director: Dr. Xiao-Hong Nancy Xu 
 
 
This dissertation focuses on the study of the toxicity of metal nanoparticles (NPs) 
and their ions on the development of zebrafish embryos, aiming to understand unique 
biological effects of NPs and ions, and design new in vivo assays to characterize the 
toxicity of these metal NPs and metal ions.  Currently, the underlying molecular 
mechanisms of biological effects of nanomaterials are partially understood.  Some studies 
assume that the toxic effects of NPs can be attributed to the release of their ions.  We 
investigate the effects of silver NPs (Ag NPs) and silver ions (Ag+ ions) on the embryonic 
development of zebrafish and compare both of their biocompatibility and toxicity. By 
statistically comparing the distributions of normal, deformed, and dead embryos, we 
conclude that the Ag+ ions cause deformities and death of developing embryos in a 
concentration dependent manner, where the critical concentration of the Ag+ ion is 0.20 
µM for chronic exposure and varies in a stage-dependent manner in acute exposures 
during specific developmental stages.  Exposure to Ag+ ions influences specific types of 
defects in development, which are far less drastic than those caused by the purified Ag 
NPs with the same amount of Ag atom.  Thus, we can conclude that toxicity of Ag NPs 
on embryonic development is not due to the release of Ag+ ions, but rather their own 
unique physicochemical properties.  We also synthesized and purified spherical Ag NPs 
(42 nm in diameter) that are stable (non-aggregated) in egg water media.  We examined 
the biocompatibility and toxicity of single Ag NPs in vivo at specific stages of development 
and the defects associated with treatment at those specific developmental stages.  We 
then developed new imaging approaches to characterize single Ag NPs as they interact 
with key brain biomarkers that are significant for neurological development in zebrafish 
embryos.  More specifically, we exposed Tg(pax2a:GFP) zebrafish embryos to various 
concentrations of the Ag NPs, and studied the effects of Ag NPs on the expression of the 
pax2a gene during treatment using fluorescent microscopy.  Sublethal concentrations of 
the Ag NPs (0.00, 0.50, 1.00, 2.00, and 5.00 pM) resulted in a phenotypical dependent 
effect on embryonic development.  However, we did not observe a significant decrease 
in expression of pax2a:GFP when exposing developing embryos to the Ag NPs.  We did, 
however, observe that a higher dose of the Ag NPs led to severe deformities.  We have 
further demonstrated the effects of Ag NPs on cardiac response. We found a decrease in 
heart-rate of both normal and deformed zebrafish, as the developing embryos were 
exposed to the Ag NPs.  Our study also shows the dose-dependent effects of Ag NPs on 
eye development, where higher concentrations of Ag NPs leads to microphthalmia in 
developing embryos.  We further studied the accumulation of Ag NPs in treated embryos.  
We found that each embryo accumulated a significant amount of Ag NPs in a dose 
dependent manner, which explains why some embryos developed normally, abnormally 
or resulted in embryonic death during treatment.  In summary, this study demonstrates 
that developing zebrafish embryos can serve as effective in vivo model organism to study 
biocompatibility and toxicity of nanomaterials and metal ions, and can potentially lead to 
better design of applications to study developmental biology.  
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   Viscosity 
ζ   Zeta potential in mV 
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cm   centimeter 
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CCD  Charge coupled device used for imaging nanoparticles with high 
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CS   Chorion space  
DFOM  Dark field optical microscopy 
DFOMS  Dark field optical microscopy and spectroscopy 
DI   De-ionized  
DLS   Dynamic light scattering 
DNA   Deoxyribonucleic acid 
EM   Electron microscopy  
FWHM  Full width at half maxima  
h   Hour  
H2O2   Hydrogen peroxide 
 ix  
 
 
hpf   Hours post fertilization  
HRTEM  High resolution transmission electron microscopy  
LSPR   Localized surface plasmon resonance  
mm    Millimeter  
MSI   Multi-spectral imaging  
mV   Millivolt  
nM   Nanomolar  
nm Nanometer 
NaBH4  Sodium tetrahydroBoride  
NaCl   Sodium chloride 
NPs   Nanoparticles  
Pax2a                      Paired box 2a gene name 
pM   Picomolar  
QDs   Quantum dots  
QY   Quantum yield  
SEM   Scanning electron microscopy 
SMD   Single molecule detection 
SPR   Surface plasmon resonance   
T Temperature in kelvin 
TCDD   2, 3, 7, 8 – tetrachlorodibenzo-p-dioxin 
TEM   Transmission electron microscopy  
Tg                            Transgenic Mutant 
UV-vis  Ultraviolet- visible  
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YS   Yolk sac  
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CHAPTER I 
OVERVIEW 
Nanomaterials pose unique physicochemical and optical properties that allow real-
time observation of cellular uptake and functions in single living cells and other animal 
models, like zebrafish embryos.1-3  These unique properties allow for their use in many 
interdisciplinary fields, and medical, industrial and commercial applications.  However, 
there is still limited knowledge about the biocompatibility of these nanomaterials.  A better 
understanding of their effects on living organisms will enable us to rationally design more 
biocompatible nanomaterials for a wide variety of applications.  The challenges with 
conventional studies and methods currently available are that they are not able to 
characterize both dose and physiochemical properties of nanomaterials in vivo and in situ 
in real time at the single cellular resolution.  Many of these studies use methods that are 
used for common chemical techniques to analyze toxicity and biocompatibility.  However, 
as shown in other studies,1-7 nanomaterials are unlike conventional chemicals because 
they are highly heterogeneous and yet single NPs have distinct physiochemical properties 
as well as highly dynamic systems that can alter over time.  Bioanalytical tools that strive 
to analyze these properties further at single cellular resolution is vastly needed and can 
tell more prominent information about their capabilities.   
Noble metal nanoparticles possess physicochemical properties that are 
exceedingly compatible in a wide range of applications, including biomedical engineering 
and design.  Silver nanoparticles (Ag NPs) possess a broad range of potential 
applications including serving as therapeutic agents and ultrasensitive optical imaging 
probes. 5, 6, 8, 9  As Ag NPs have also been used in consumer products, the potential 
The journal this dissertation follows is ACS Nano 
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release of Ag NPs to aquatic environments could lead to adverse health impacts on 
humans.   
Ag NPs possess distinct plasmonic optical properties and very high Rayleigh 
scattering.  Because Ag NPs resist photobleaching and photoblinking, the optical 
properties allow our lab to design Single Nanoparticle Optical Biosensors (SMNOBS) that 
distinctively overcomes the optical drawbacks of other fluorescent super-resolution 
imaging methods.  We have demonstrated that single Ag NPs can serve as superior 
photostable optical molecular probes and sensors for imaging of single biomarker 
molecules, probing ligand-receptor interactions in real time, and imaging single live cells 
and embryos in real time, using dark-field optical microscopy and spectroscopy (DFOMS). 
5  
Previous studies from our group have explored in depth how nanotoxicity can 
contribute to malformations and abnormalities in embryonic development.  We have 
designed ultrasensitive in vivo bioanalytical imaging tools to address the questions of 
toxicity and biocompatibility of nanoparticles in living systems by using zebrafish embryos 
as our in vivo animal model.  Zebrafish (Danio rerio) serves as an excellent model 
organism to study human development and physiology, human diseases, and toxicity 
screening for many potential drugs. They have many distinct advantages over other in 
vivo models like mice and rats.  Zebrafish embryos have a rapid developmental process 
where they will complete embryogenesis within 120 hours post fertilization (hpf).  This is 
faster than most animal models used in other studies.  During their development, 
zebrafish embryos are transparent.  This enables real-time monitoring and studying the 
effects and transport of single NPs.  This also allows for direct imaging of molecular 
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changes and abnormalities during embryogenesis.  Because zebrafish has a genetic 
makeup that is similar to humans, zebrafish have been used in many screenings for 
therapeutic agents and toxicity studies of many conventional chemicals and drugs. 10-16  
Transgenic zebrafish are highly used as the go-to in vivo animal model for the exploration 
of the molecular development and for the design of newer imaging tools used in many 
labs. 17-19  Using these transgenic models has allowed many researchers to essentially 
study biomarkers that were otherwise impossible to research in vivo.   
In developmental biology, embryonic development is still not fully understood, but 
with the help of transgenic zebrafish in vivo models, much has been accomplished within 
the last decade, which has contributed to improving the design of transgenic models to 
study mechanisms regulated by embryogenesis.  The biological functions that are 
enabled during embryogenesis are highly regulated and complex processes that involve 
many different macromolecules that are still being identified.  Our lab is particularly 
interested in neurological development because this is the central control center of living 
systems.  Neurological development has many dynamic processes that still puzzle the 
neuroscience and developmental biology community.  Understanding how the developing 
brain and all of its components are regulated and function will aid in establishing better 
molecular assays to further explore these and similar questions, leading to the increase 
of knowledge in the field of neuroscience.   
For this dissertation, we explored in vivo assays and applications to study silver 
nanoparticles (Ag NPs) and silver ions (Ag+ ions) upon their effect on embryonic 
development, and also the molecular mechanism of embryonic neurological development 
and how nanomaterials can influence and alter this development over time.  Each study 
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discussed will highlight a significant bioanalytical design that will allow further exploration 
into key developmental stages that can contribute to the understanding of biomedical 
applications using nanomaterials.  This dissertation includes six chapters. In Chapter I, 
we provide a brief overview of the research background, the significance of this 
dissertation research, and outline the contents of each chapter. 
In Chapter II, we describe the design of standard in vivo toxicological assays that 
are efficient, easy to use, and affordable to screen the toxicity of silver cations during 
embryogenesis, as illustrated in Figure 1.  To this end, we have demonstrated an 
ultrasensitive method to study the toxicity of Ag+ ions on zebrafish embryos aiming to 
assess nanotoxicity on embryonic development, heart functions, and hatched time. Dose-
dependent toxic effects of the Ag+ ions on embryonic development were observed, 
showing that the number of zebrafish developed normally decreased while the number of 
dead zebrafish increased as Ag+ ion concentrations increased. The Ag+ ions not only 
interfere with embryonic development but also heart development and functions. We 
observed heart deformities and lower heart rates in zebrafish exposed to Ag+ ions. 
Studies are needed for a more in-depth mechanistic understanding of Ag+ ion induced 
heart deformities. Moreover, delays in hatching mechanisms of treated zebrafish were 
observed in a dose-dependent manner. Zebrafish embryos exposed to high 
concentrations of Ag+ ions hatched later.  
In Chapter III, we investigated the effects of silver cations to determine their effects 
on various developmental stages and their related mechanisms as illustrated in Figure 2.  
To this end, we incubated the embryos with Ag+ ions for two hours and characterized their 
effects upon embryonic development over time using a wide variety of bioanalytical tools.   
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We found that the effects of silver cations on embryonic development highly depended 
upon embryonic developmental stage and incubation time.  We also saw concentration 
and stage dependent effects of Ag+ ions on hatching rate and cardiac response. The 
results demonstrated the need for future investigation of heavy metal toxicity exploring 
key developmental stages. 
In Chapter IV, we continued our in vivo assay design to explore the biocompatibility 
and toxicity of 41.5 nm Ag NPs in zebrafish embryos at key developmental stages, as 
illustrated in Figure 3.  To determine the specific effects of Ag NPs on various 
developmental stages and their related mechanisms, we incubated the embryos with Ag 
NPs for two hours and characterized their effects upon embryonic development over time 
using similar bioanalytical tools described in chapter II and chapter III.  We found that 
the effects of NPs on embryonic development highly depended upon the embryonic 
developmental stage, incubation time, the size and dose of NPs.  
In Chapter V, we used our in vivo model to investigate the mechanisms of effects of 
purified and well-characterized nanoparticles (NPs) on embryonic developments, 
specifically neurological development.  To that end, we selected a vital protein biomarker 
that plays an important role in neurological development, used transgenic embryos that 
express the protein biomarker fused with fluorescence proteins as model organisms, and 
studied the effects of NPs on their functions using fluorescence microscopy and 
plasmonic spectroscopy. 
In Chapter VI, we summarized our research findings described in the preceding 
chapters, pointed out the primary contributions of these original research activities, and 
emphasized the possible future research directions.  
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Figure 1: Schematic illustration of in vivo study of chronic treatment of silver 
cations on embryonic development. 
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Figure 2: Illustration of probing of stage-dependent toxicity of AgNO3 using 
zebrafish embryos. 
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Figure 3: Illustration of using 43 nm, Ag NPs to study the biocompatibility and 
toxicity in living zebrafish embryos in real-time at specific developmental stages. 
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Figure 4: Illustration of using 43 nm single Ag NPs to study the toxicological effects 
on neurological development in zebrafish embryos in real-time. 
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CHAPTER II 
IN VIVO STUDY OF CHRONIC TREATMENT OF SILVER CATIONS ON EMBRYONIC 
DEVELOPMENT 
INTRODUCTION 
Heavy metals have been widely used in multiple fields from domestic and 
industrial, to medical and technological applications.  With this wide distribution of use 
across many fields, their potential impact on both environmental and biological health has 
been well studied over the years.  Understanding the impact requires studies to 
understand the mechanisms of exposure and toxicity.  Some toxicological studies of some 
heavy metals, such as cadmium and mercury have shown that heavy metals and their 
ions can lead to genetic mutations and functional decrease in biological systems. 20-23  
Other studies have shown a loss of enzyme stability and an increase of apoptotic 
biomarkers in vitro when exposed to heavy metals such as titanium and zinc. 24, 25  These 
studies have allowed for modifications to be made when utilizing heavy metals in research 
and applications.  Although many strides have been made to understand the toxicity of 
heavy metals, a better approach and application is needed to address early 
developmental adversities from heavy metal exposure. 
Silver metal has been used throughout the decades for its unique properties.  
Silver ions (Ag+ ions) and their toxicological exposure have been of great concern with a 
very significant increase of silver being used in nanotechnology. 26-31  This increase is in 
response to silver’s antimicrobial and antibacterial properties.  Silver nanomaterial has 
shown increasing use in consumer products (such as clothing and home appliances) as 
well as in biomedical applications (such as biosensors and imaging probes).  Although 
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increasingly used in biomedical applications, understanding the biocompatibility of silver 
nanomaterial is essential for their success in clinical applications. Our studies have shown 
a toxicology concentration and stage dependent effect of Ag nanoparticles on embryonic 
development.   
Many suggest that the toxicity of Ag NPs is reflected in the ionic properties of silver.  
Some attribute the toxicity of Ag NPs to the dissolution of Ag ion, without a direct link of 
the ionic relationship with NP toxicity.  In order for us to understand nanoparticle toxicity 
to rationally design more biocompatible nanoparticles, we must understand the 
mechanism of toxicity of the nanomaterial, thus we can rationally design more 
biocompatible applications.  
Zebrafish (Danio rerio) have been extensively used as an in vivo model for 
embryological development because of its small size, its short breeding cycle, and the 
wealth of information available for manipulation.  The zebrafish is transparent throughout 
development, allowing for surveillance of development from outside the chorion without 
disturbing its developmental process.  Zebrafish can spawn in large numbers from week 
to week, producing large masses of fertilized eggs, which are ideal for observing different 
developmental stages.  The embryonic development is so fast and efficient that primary 
organ development is completed within the first 48 hours post fertilization (hpf), and the 
normal embryo will hatch and swim by 72 hpf.  Since zebrafish are so genetically similar 
to other organisms and even humans, zebrafish have been widely used for chemical and 
drug analysis and screening.  Our group was the first to use the zebrafish to study the 
toxicity of nanomaterials. Therefore, zebrafish embryos offer a unique opportunity to 
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investigate developmental processes upon treatment with heavy metals to determine the 
adverse effects during development. 
Here, we investigate the roles of Ag+ ions on embryonic development in 
comparison to our previous studied silver nanoparticles.  Here, zebrafish embryos were 
chronically exposed to silver nitrate in corresponding concentrations that corresponded 
to the published toxicological concentrations of our Ag NPs studies.  Phenotypic and 
survivability observations can be compared to other toxicological studies.  Heartbeat 
analysis was also studied to show the effects of ionic concentrations on cardiac function.  
Analysis was also carried out on embryo hatching mechanisms from treatment with Ag+ 
ions.   
RESULTS AND DISCUSSION 
Early-developing embryos as in vivo model organisms and assays  
Zebrafish embryos have recently gained interest as being an optimal animal model for 
toxicity and genetic studies.  Zebrafish has several unique properties that allow them to 
be a well-defined animal model.  Optical images in Figure 5 A-B show normal 
developmental zebrafish embryos at cleavage (0.75-2.25 hours-post-fertilization, hpf), 
germ ring stage (8-10 hpf), late segmentation (24 hpf), hatching (48 hpf), hatched embryo 
(72 hpf), and fully developed larvae (120 hpf). Fast embryogenesis allows rapid multiple 
studies to be performed in a shorter amount of time than using other animal models that 
take longer to develop.  Because zebrafish are optically transparent during 
embryogenesis, which is a characteristic of using zebrafish embryos, monitoring of 
cellular division and migration as well as the development of primary and secondary 
organs can be observed and characterized. This allows for real-time monitoring and 
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analysis of the effects of toxins on development can be observed during the experiment.   
Furthermore, a large number of embryos can be generated rapidly (overnight) at very low 
cost, serving as high-throughput in vivo assays to screen biocompatibility and toxicity of 
many toxins and materials.  Zebrafish have gained a lot of focus from genetic and 
developmental biologists because of the similarity with humans in genetic makeup.  
Behavioral studies using Zebrafish have led to many breakthroughs in neurological 
development allowing scientists to explore mutated genes and disarrayed pathways that 
have been found to occur in early stages of neurological abnormalities. 
Using embryos in vivo in studies have numerous advantages over in vitro cultured 
cells for the study of biocompatibility and toxicity of metal ions.  For instance, in vivo assay 
enables one to investigate the effects of heavy metals upon different development stages 
of cells while studying multiple others all in one organism. Thus, the selection of zebrafish 
embryos as our animal model to study the toxicity of silver ions was our preference. 
Study of concentration-dependent toxicity of Ag+ on embryonic development 
To study the concentration dependent toxicity of our silver ions, we incubated 
cleavage-stage embryos (2-4 hpf) with a series of concentrations of AgNO3 (0-1.20 µM) 
that was suspended in egg water for 120 hours (h).  Representative embryonic 
developmental stages were imaged and assayed every 24 h over 120 hpf until the 
embryos fully developed (Figure 6A). We determined and characterized the number of 
embryos that developed to normal zebrafish (Figure 5A), died (Figure 6B), or developed 
into deformed zebrafish (Figure 5A). The results in Figure 6 show various degrees of 
dependence on embryonic development upon the concentrations of AgNO3. As the ion 
concentration increased from 0 to 1.20 µM, the number of embryos that developed to  
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Figure 5. Optical images of zebrafish embryos.  
(A) Cleavage stage embryo (0.75-2.25 hpf) incubated with AgNO3 (0.00-1.20 µM) over 
120 h at 28.5oC.  (B) Normally developing embryos: (a) germ-ring stage (8-10 hpf); (c) 
late segmentation stage (24 hpf); (d) hatching stage (48 hpf); (d) protruding mouth 
pharyngula stage (72 hpf); and (e) fully developed larvae (120 hpf) lateral view. (C) Dead 
embryos. (D) Abnormally developed embryos at 120 hpf showing (a-b) finfold 
abnormality; (c-d) tail/spinal cord flexure and truncation; (e-g) pericardial sac edema and 
yolk sac edema; and (h) eye and head abnormities.  Many of the deformed zebrafish had 
multiply types of deformities.  Scale bar for (A -C) = 200 µM; Scale bar for (D) = 250 µm. 
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normal zebrafish decreased, while the number of embryos that became dead or 
developed to the deformed zebrafish increased, given way to a concentration 
dependency of AgNO3. 
High concentrations of the silver ion generated several common and severe 
deformed zebrafish (Figure 5D) observed starting at 48 hpf in the embryos exposed to 
0.2-0.8 µM AgNO3, which included: (a-b) finfold abnormality; (c-d) tail/spinal cord flexure 
and truncation; (e-g) pericardial sac edema and yolk sac edema; and (h) eye and head 
abnormities.  The distributions of types of deformities versus the Ag ion concentrations in 
Figure 7 show that more embryos develop to severely deformed zebrafish (e.g., cardiac 
malformations and head abnormalities) in the 0.3 and 0.4 µM AgNO3. 
Interestingly enough, the most severe deformities that showed multiple 
abnormalities were observed in the 0.4 and 0.8 µM concentrations.  Taken altogether, 
these interesting findings show definite concentration dependent toxic effects of Ag ion 
upon embryonic development. This is interesting, considering EPA guidelines for Silver 
Acute toxicity falls within the toxicity range of 2-3 µg/L silver ion. 32  Table 1 shows 
representative images of deformities for each concentration treatment group.  These 
deformities were scored from 1 being the least severe in abnormality and 4 being the 
most severe in abnormality.  As we can see, the more severe deformed zebrafish were 
captured in the 0.3 – 1.2 µM, where head abnormalities and eye abnormalities were 
prevalent.  We did observe that the more severe zebrafish with these abnormalities also 
had multiple other deformities like pericardial sac edema and yolk sac edema. 
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Figure 6: Biocompatibility and toxicity of Ag+ Ions show dependency on its 
concentration.   
Histogram of distribution of normally developed (green), dead (red), and deformed (blue) 
zebrafish versus concentration of the Ag+ ion for (A) 4 hpf; (B) 24 hpf; (C) 48 hpf; (D) 72 
hpf; (E) 96 hpf; and (F) 120 hpf.  The means and standard deviations (error bars) of the 
total number of embryos that developed normal and deformed, or became dead shown 
for each given concentration are from triplicate measurements. 
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  Since toxicity of metal ion nanomaterials has been cited to be caused by the 
leaching or exposure to the metal ion, we decided to evaluate the overall toxicity Silver 
Nanoparticles to our toxicity levels in this study.33-38  We found that the abnormalities 
observed from the exposure of the Ag+ ions (finfold abnormality, tail flexure, yolk sac 
edema, pericardial sac edema, and eye and head abnormalities) where all similar to those 
exposed to Ag NPs. 33, 35, 37, 38  This suggests that the toxicity biological mechanisms that 
are involved in the formation of these abnormal developments (i.e. molecular biomarkers 
and genetic pathways) are similar between Ag+ and Ag NPs, which are still not well 
understood.  However, the lethal level of toxicity in Ag NPs was found to be much lower 
when converted to Ag+ molarity concentrations for comparisons, where concentrations 
was in the nanomolar range.  Thus, challenging the theory that the toxicity of metal and 
metal oxide nanoparticles, or in this case Ag NPs, is related to the release of the Ag+ ion. 
Study of effects of Ag+ on hatching of embryos 
Zebrafish embryos will hatch out of their chorions after organogenesis for 
survivability.  The longer the embryo stays inside the chorion may lead to the embryo 
being more susceptible to predators or abnormal growth. 39  During natural hatching, the 
chorion is digested from the inner surface, and tail movements of the embryo help to 
break the remaining chorion.  This hatching usually happens between 48-72 hpf.  Many 
studies have reported the delay in hatching after exposure to different toxins. 28, 30, 36, 40 
Mechanisms of this delay, although not widely understood, has been theorized to be 
because of the hardening of the outer layer of the chorion, making it difficult for the embryo 
to break free.  Effects of Ag+ ions on this hatching process has not been widely studied in 
zebrafish. 
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Figure 7: Deformities of Zebrafish resulted from being treated chronically by 
AgNO3.  
Histograms of the percentages of Zebrafish with five representative types of deformities 
versus concentration of Ag+ ions; (a) finfold; (b) tail flexure; (c) yolk sac edema; (d) eye 
abnormality; (e) head abnormality; and (f) pericardial sac edema.  The means and 
standard deviations (error bars) of the total number of embryos that developed each type 
of deform shown for each given concentration are from triplicate measurements.   
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  Number of Zfish with 
Severity Scale 
 
C 
(µM) 
Images of Zebrafish 0 1 2 3 4 
Number of 
Dead 
Embryos 
0 
Normal Development 74 ±1.8     2 ±0.5 
 
 
 
 
     
 
0.05 Normal Development 74±1.8     2±0.5 
0.1 
Pericardia Sac Edema, Finfiold Abnormities 73±1.8  1   3±0.8 
 
 
        
0.2 Pericardia Sac Edema, Finfiold Abnormities 46±3.4  1 1 2 24+3.4 
 
 
 
       
0.3 
Head and Eye Abnormities, Yolk Sac 
Edema, Pericardial Sac Edema, Tail 
Flexures 
17±1.0 4 3 4 9 34±1.5 
 
 
       
  
      
0.4 
Head and Eye Abnormities, Yolk Sac 
Edema, Pericardial Sac Edema 
9±1.5 3 6 2 9 52±2.1 
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0.8 
Head and Eye Abnormities, Yolk Sac 
Edema, Pericardial Sac Edema 
0±0    7 68±1.0 
 
 
      
1.2 
Head and Eye Abnormities, Yolk Sac 
Edema, Pericardial Sac Edema 
0±0    2 70±2.0 
 
 
      
 
Table 1: Summary of Dependence of Number of Normal and Deformed Zebrafish 
upon concentration of AgNO3.  
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To study hatching, observations were made every 2 hours to identify what hpf the 
embryo hatched from the chorion.  Figure 8 shows that as the concentration of Silver 
nitrate increase, embryo hatching time was decreased.  The controls hatched out of 
chorions around 50-60 hpf.  Lower concentrations, 0.05-0.1µM, also showed a normal 
rate in hatching time.  However, the higher concentrations, 0.20-0.80 µM, µM showed a 
hatching rate up until 96 hpf.  This delay in hatching does show a concentration 
dependency.  We also noticed that deformed zebrafish hatched out at a later rate than 
those zebrafish that developed normally.  These deformed zebrafish could potentially be 
delayed in hatching because of a lack of physical abilities to move, as well as a delay in 
chemical release of hatching enzymes.  Further genetically studies could be used to 
reflect these enzyme levels during hatching.   
Quantitative study of effects of Ag+ on heart rate of developing embryos  
Heartbeat analysis was taken at 24, 48, and 120 hpf by visually counting of the 
beats per minute and compared between concentrations, as well as normal or abnormal 
development Figure 9A shows the quantitative results of those zebrafish that were 
normally developed at each time point. Heart rates show a decreasing effect as the 
treatment concentration increases, with a significant decrease at 48 and 120 hpf for the 
0.4 µM treated zebrafish.  Figure 9B shows the quantitative results of those zebrafish that 
were abnormally developed at each time point. There is a significant decrease, again, 
with the higher concentration (0.8 µM) compared to the other two concentrations.  These 
results do, in fact, reflect that higher silver ion concentrations have an effect on cardiac 
function.  
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  We observed a significant difference in heart rate between normal development 
and deformed zebrafish at those treated ion concentrations that had both normal and 
deformed zebrafish.  This demonstrated an adverse effect on cardiac development in 
embryos treated with silver nitrate. 
Study of accumulation of Ag+ ions in developing embryos 
Treatment solution from each individual zebrafish larvae was analyzed before and 
after the treatment of the ion using GF-AAS.  Figure 10 shows the amount of Ag+ that was 
accumulated in the individual normal larvae (a), deformed larvae (c), and those embryos 
that were dead (e) by the end of the 120 hr treatment plotted over at the different 
concentrations.  The averages of those normal (b), deformed (d), and dead (f) embryos 
are also shown in the plots.  From the results, we show that the amount of Ag+ found in 
the 0.4-1.2 µM abnormally developed larvae was not significantly different from those that 
were dead by the end of the treatment in the same concentrations.  However, we do see 
a significant difference in the 0.4 and 0.8 µM treated larvae that developed normally 
compared to the deformed and dead larvae. The accumulation rate is much longer at the 
end of exposure for those larvae that developed normally.  This could suggest that the 
zebrafish that developed normally were able to extrude the Ag+ from its system, allowing 
it to function normally under heavy metal exposure, compared to those who either died 
during exposure or developed abnormally.   
SUMMARY 
In conclusion, we have demonstrated an ultrasensitive method to study the toxicity 
of Ag+ ions on zebrafish embryos aiming to assess nanotoxicity on embryonic 
development, heart functions, and hatched time. Dose-dependent toxicity effects of the 
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Ag+ ions on embryonic development were observed, showing that the numbers of 
zebrafish developed normally decreased while the numbers of dead zebrafish increased 
as Ag+ ion concentrations increased. The Ag+ ions not only interfere with embryonic 
development but also heart development and functions. We observed heart deformities 
and lower heart rates in zebrafish exposed to Ag+ ions. Further studies are needed for a 
deeper understanding of how Ag+ ions cause heart deformities from a mechanistic 
perspective. Moreover, delays hatching in zebrafish were observed in a dose-dependent 
manner. Zebrafish embryos exposed to high concentrations of Ag+ ions hatched later. 
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Figure 8: Study of hatching rate of zebrafish treated chronically by AgNO3.  
Histogram of the percentages of Zebrafish that successfully hatched during the exposure 
to the Ag+.  Newly hatched embryos were observed every 5 hours during incubation and 
recorded at (a) 56 hpf in black; (b) 66 hpf in pink; (c) 76 hpf in cyan; (d) 86 hpf in purple; 
and (e) 96 hpf in orange.  The means and standard deviations (error bars) of the 
percentage of total number of embryos that hatched at given time points shown for each 
given concentration are from triplicate measurements.  
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Figure 9: Study of heart rates of zebrafish treated chronically by AgNO3.   
(A) Plotted graph of the average heart rate and standard deviation (error bars) of normally 
developed Zebrafish exposed to the Ag+.  Heart Rates were recorded at (a) 24 hpf in blue; 
(b) 48 hpf in orange; and (c) 120 hpf in green.  Total number of zebrafish counted during 
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the study represented at each time point as (d) 24 hpf as blue bar; (e) 48 hpf as orange 
bar; and (f) 120 hpf as green bar.  (B) Plotted graph of the average heart rate and standard 
deviation (error bars) abnormally developed Zebrafish exposed to the Ag+.  Heart Rates 
were recorded at (a) 24 hpf in blue; (b) 48 hpf in orange; and (c) 120 hpf in green.  Total 
number of zebrafish counted during the study represented at each time point as (d) 24 
hpf as blue bar; (e) 48 hpf as orange bar; and (f) 120 hpf as green bar. 
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Figure 10: Study of Ag+ ion uptake in zebrafish treated chronically by AgNO3 since 
their cleavage stage shows concentration dependency.   
Histogram of the number of micromoles (µmole) of Ag+ that was uptake by the embryo 
during treatment. Treatment solution was collected before and after ion exposure and 
analyzed using GFAAS.  The recovered ionic moles was plotted against the concentration 
of the treatment solution for each (A) Normal developed larvae with (a) green circle being 
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individual normal larvae and (b) green triangle being the average of the individual normal 
larvae; (B) Abnormally developed larvae with (c) blue circle being individual deformed 
larvae and (d) blue triangle being the average of the individual deform larvae; or (C) dead 
embryos with (e) red circle being individual dead embryos and (f) red triangle being the 
average of the individual dead embryos, to represent the zebrafish embryo at 120 hpf 
after treatment. 
  
 29  
 
 
MATERIALS AND METHODS 
Reagents and supplies 
Deionized (Di) water (18 MΩ, Barnstead) was used to prepare all solutions.  AgNO3 
was purchased from Sigma and stored in small premeasured aliquots in small amber 
bottles until treatment solution preparation.  
Breeding and monitoring of zebrafish embryos  
Wild type adult zebrafish (Aquatic Habitats) were raised and maintained as 
previously described. 41-44  A 4:3 (female: male) ratio of breedable adult zebrafish were 
set up the night before the experiment in a 10.0 L clear housing tank (Pentair Aquatic 
Habitats) for mating using fresh circulated system water maintained at 28.5°C.  Once the 
light was on the next morning (14 h light: 9 h dark circadian cycle), adults were allowed 
to chase and breed until a sufficient amount of embryos were present.  Healthy fertilized 
embryos were collected into fresh system water using a siphoning collection hose.  Once 
collected, healthy embryos were transferred into a petri dish containing egg water (1.0 
mM NaCl) and washed three times with egg water to remove the surrounding debris.  All 
experiments involving embryos and zebrafish were conducted in compliance with IACUC 
guidelines (protocol # 15-012).  
Study of concentration-dependent toxicity of Ag+ on embryonic development 
Once embryos reached cleavage stage (2 hpf), embryos were treated in egg water 
and incubated with a dilution series of AgNO3 (0.00, 0.05, 0.10, 0.20, 0.30, 0.40, 0.80, 
and 1.20 µM) in  24-well plates for 120 h, one embryo per well. The treated embryos were 
incubated in a water bath at 28.5 °C for 120 h for which no light was provided to prevent 
photodecomposition of the Ag+ ion. The developing zebrafish embryos were imaged over 
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time at 0, 24, 48, 72, 96, and 120 hpf by bright field optical microscopy using an inverted 
microscope (Zeiss Axiovert) equipped with a CCD camera (Coolsnap, Roper Scientific) 
and a color camcorder (Sony). Twelve embryos were studied for each concentration in 
one run of the experiment and three replicates of the runs were used, bringing the total 
number of 36 embryos studied for each concentration. 
Study of hatching rate of zebrafish upon Ag+ concentrations 
When the embryos developed to the hatching stage of developed (48 hpf), we 
monitored the embryos every 2 hours for any newly hatched from the embryonic barrier 
of the chorions.  Newly hatched embryos were imaged for any abnormities.  Hatching rate 
was then determined each concentration by counting the number of newly hatched 
embryos at each given time point and graphed over time.      
Quantitative study of heart-beat of developing zebrafish upon Ag+ concentrations 
Both treated and control embryos were analyzed for heart rates.  Embryos were 
recorded using the Sony camcorder and Coolsnap Ez (Roper Scientific) using 100 frames 
with a 50 ms interval delay.  The recordings were taken at 24, 48, and 120 hpf.  The 
movies were then converted and analyzed for manual counting of the hearts contractions.  
The heartbeat per minute was then compared graphically to both the normal and 
abnormal developed fish at each concentration. 
Study of the accumulation of Ag+ in zebrafish embryos using GF-AAS 
A series of dilutions of standard solutions of Ag+ was prepared using Silver 
spectrometric standards (100 ppm) for calibration purposes.  Treatment solution from 
each individual zebrafish embryo was pipetted out at the beginning and end of the 
treatment into 2 mL centrifuge tube.  Samples were briefly centrifuged to remove any 
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embryo debris.  Each solution was analyzed using GF-AAS (Shimadzu Atomic Absorption 
Spectrophotometer AA-7000 Series).  Calculations were made to determine the uptake 
of the ion by the embryo by subtracting the initial silver ion concentrations from the final 
silver ion concentrations.  The final delta concentration, ΔC, was then plotted over the 
treated concentrations.   
Data analysis and statistics 
Each experiment related to this study was performed at least four times and a total 
of 70-75 embryos for each experiment were studied to gain sufficient data for statistical 
analysis, permitting the study of the effect of AgNO3 on a bulk amount of embryos at the 
single embryo level.  We presented averaged the number of normally developed, dead 
and deformed zebrafish vs. Ag+ concentration with standard deviations.  We used 
conventional statistical analysis methods (t-test, ANOVA, Tukey’s, SigmaStat 3.5 with P 
= 0.05) to determine the significance of the different observations between all 
concentrations for development, hatching, heartrate and uptake results.  A Pairwise T-
test comparison was performed of Deformities Histogram. 
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CHAPTER III 
IN VIVO STUDY OF THE ACUTE TOXICITY OF SILVER IONS ON EARLY 
DEVELOPMENT OF ZEBRAFISH EMBRYOS 
INTRODUCTION 
 Nanomaterials exhibit distinctive physicochemical properties leading to their 
unique functions and a wide range of potential applications in engineering, medicine, and 
electronics. For example, their surface areas allow effective surface modification for more 
effective and more specific in order to increase drug efficacy. Silver nanoparticles (Ag 
NPs) have also been increasingly used in consumer products such as socks, home 
appliances, and disinfectants.45-53  The potential release of NPs into aquatic environments 
could have an adverse impact on human health.54 Thus many studies have indicated 
toxicity of nanomaterials including Ag NPs in living organisms. For example, trace 
concentrations of Ag NPs result in death and deformities in zebrafish. In the environment, 
some types of nano-metals will gradually dissolve by dissolution of metal ions from the 
surface of the particle. In addition to nanomaterial toxicity, Ag+ ions could possibly lead to 
adverse environmental impacts as Ag+ ions have been utilized as salt precursors in Ag 
NP synthesis. Ag+ ions have been reported to interact with thiol groups which are found 
in antioxidant resulting in oxidative stress.32 Moreover, metal ions including Ag+ ions can 
also inhibit the bronchial Na+/K+-ATPase. Ag+ ions causing osmoregulatory failure in fish. 
For example, low concentrations of Ag+ ion as low as 1.7 ng mL-1 resulted in a reduction 
in the Na+, K+-ATPase activity in rainbow trout (Oncorhynchus mykiss) gill. 55 
Zebrafish (Danio rerio) embryos can serve as an important model organism to 
study aquatic environmental toxicity because of numerous advantages, including (i) the 
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rapid embryonic development (within 120 h) with well-defined developmental stages ex 
utero, which facilitates experimental manipulation and allows the direct observation 
organogenesis in vivo; (ii) massive amounts of zebrafish embryos can generate at once 
providing high throughput screening animals to analyze; (iii) the organization of the 
genome and the genetic pathways controlling signal transduction and development are 
highly conserved between zebrafish and human.  
Zebrafish are time efficient for care and maintenance and they effortlessly spawn 
in large numbers from week to week producing macroscopic fertilized eggs, which are 
ideal for observing different developmental stages.56-60  The embryonic development is 
so rapid that the first stages of development are completed in the first 24 hours post 
fertilization (hpf) and the normal embryo will hatch and swim by 72 hpf.  The majority of 
developmental mutations identified in zebrafish have close counterparts in other 
vertebrates, suggesting that this system can be effectively used as a model for 
understanding the developmental processes of higher organisms, including humans.40, 61-
63   
Despite superior intrinsic properties of zebrafish embryos, they have not yet been 
widely used as a standard in vivo assays for screening of biocompatibility and toxicity of 
nanomaterials and metal ions at specific developmental stages.  Our lab was one of the 
first groups to utilize this model to study size-dependent and stage-dependent 
biocompatibility on smaller size Ag NPs using this animal model.  64 
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RESULTS AND DISCUSSION 
Study of effects of Ag+ on different developing stage of embryos 
 The normal course of embryonic development in zebrafish in the absence 
of Ag+ ions for each acute treatment stage is depicted in Figure 11.  Acute treatment 
occurred at five different stages of development for a 2 hour incubation time with silver 
ions: stage I, cleavage stage (2-4 hpf) (Figure 11 A (a)), stage II, gastrula stage (6-8 hpf) 
(Figure 11 A (b)), stage III, early segmentation stage (12-14 hpf) (Figure 11 A (c)), stage 
IV, late segmentation stage (21-23 hpf) (Figure 11 A (d)) and stage V, hatching period 
(48-50 hpf) (Figure 11 A (e)).  During stage I, the embryo will undergo dramatic changes 
like rapid cellular division and meticulous embryonic pattern formation.51, 65, 66  During 
stage II, embryos will undergo cell migration, early gastrulation for the establishment of 
organ and organ system development.66-69  Stage III and stage IV is the segmentation 
stages.  In stage III, embryos will begin somitogenesis and notochord formation, which is 
important for proper development of the axial skeleton, the vertebrate spinal column, and 
skeletal muscle.69-72  During stage IV, embryos will undergo cardiovascular and 
circulatory development where the first embryonic heartbeat and pumping can be 
observed.62, 69  Stage V is the hatching stage, where the primary organs of the embryo 
would have underwent development, and the embryo will hatch out of its protected 
chorion to finish its development.  Their developmental stages were selected because of 
their importance during embryogenesis.  Changing the embryonic environment and 
exposure of toxins and chemicals during these stages have been known to influence 
embryos phenotypical development and survivability.  These development stages are 
proven to be the most sensitive to exposure. 62, 63 
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 Embryos at each stage were observed throughout development after acute 
treatment with Ag+ ions.  Stage I-IV embryos were observed after acute treatment at 24 
hpf (Figure 11 B (a)), 48 hpf (Figure 11 B (b)), 72 hpf (Figure 11 B (c)), 96 hpf (Figure 11 
B (d)), and 120 hpf (Figure 11 B (e)).  Stage V embryos were only observed after acute 
treatment at 72 hpf through 120 hpf, (Figure 11 B (c-e)).   
Concentration and development stage dependent toxicity study 
 Danio rerio embryos exposed to sublethal concentrations of Ag+ ions acutely at 
selected stages revealed that Ag+ ions induced death, as well as variations in the severity 
of morphological defects, increasing with increasing concentrations of the Ag+ ion.  Figure 
12 shows the overall status of controls and treated embryos at 120 hpf for each Acute 
Stage.  Stage I is shown in Figure 12A, stage II is shown in Figure 12B, stage III is shown 
in Figure 12C, stage IV is shown in Figure 12D, and stage V is shown in Figure 12E.  The 
critical concentrations for each stage are shown in Table 1.  Here, we define the critical 
concentration of the Ag+ ions at which only 50% of embryos develop normally. 
Stage I resulted in an increasing number of deformities in Ag+ treated embryos as 
the concentration increased (Figure 12A), with a critical concentration of least than 0.1 
µM.  Even after exposure to the lower concentration of silver ions, stage one treatment 
resulted in abnormalities.  With increasing concentration, there was also an increasing 
number of embryonic deaths.  At the two highest tested concentrations, a majority of 
embryonic death was observed.  Because this stage is prominent for rapid cellular 
division, exposure of Ag+ ions at this stage can significantly influence the development of 
embryos long term.  Thus we see a significantly lower critical concentration at 0.1µM, 
which is the lowest for all five treatment stages.     
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 Embryos treated in stage II had an increasing rate of embryonic death observed in 
higher concentrations.  Formation of deformities were also observed amongst the lowest 
treated Ag+ ion concentration.  Critical concentration for stage II was observed at 0.2 µM.  
Stage II appeared to display an ample amount of abnormal development amongst all 
treatment groups when compared to all other stages.  The highest number of deformed 
embryos were observed in stage II.  As the concentration of Ag+ ion also increased, there 
was a decrease in normally developed embryos, and correspondingly, an increased in 
embryonic death.  The highest concentration treated resulted in complete elimination of 
normally developed embryos, with only abnormal or death displaying.  The early 
gastrulation stage is significant because at this stage, cellular movement is observed, 
where cells start to migrate into positions that will determine their cellular fate.   
 Stage III shows that embryo treated at this time point did not have drastic 
embryonic death until the two highest treated concentration (Figure 11 a).  At those 
concentrations, there was a majority of embryonic death amongst treated embryos.  This 
stage presented the lowest amount of abnormally developed embryos from all treatment 
groups.  The critical concentration was determined to be between 0.40 – 0.80 µM.  Stage 
III is the early segmentation stage where the notochord and spinal cord are heavily 
influenced.   
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Figure 11: Normally developed zebrafish at stages I – V at the time of acute 
treatment and observations after acute treatment.   
(A) Representative optical images of normally developed zebrafish at the time of acute 
treatment for stage I – V, (a) 2 hpf (cleavage stage); (b) 6 hpf (early gastrula stage); (c) 
12 hpf (early segmentation stage); (d) 21 hpf (late segmentation stage) and (e) 48 hpf 
(hatching stage).  (B) Representative optical images of normally developed zebrafish 
observations after acute treatment for stages I – IV, (a) 24 hpf (late segmentation stage); 
(b) 48 hpf (hatching stage); (c) 72 hpf (pharyngula stage); (d) 96 hpf larvae and (e) 120 
hpf fully developed larvae.  Note that observations for stage V began at (c-e).  Scale bar 
= 250 µm. 
 
A 
a b c d e 
a b c d 
e 
B 
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  Stage V was the least sensitive to toxic treatment stage out of all acute 
stages.  At this stage, there were a significant number of embryos which were not affected 
by the Ag+ ion treatment.  There was abnormal development in each treatment group, but 
the toxic effects of the ion were slightly less than the other concentrations.  The most 
embryonic death was at the highest treatment concentration, where at least 50% of the 
embryos did not survive.  The critical concentration was 0.80 µM.  This stage also showed 
the most amount of embryonic survivalist between all stages.  At this stage, the embryo 
will start hatching out of their chorions, because of the primary organ development.  These 
results show the embryo is less affected by the exposure of the silver ion at this stage. 
From our previous studies, we were able to compare the toxicity effects of Ag+ to 
our Ag NPs studies.  These results show that the toxicity of single Ag NPs, at different 
sizes, have a more toxic effect acutely than their bulk counterparts. 
We treated stage I through V embryos acutely with increasing concentrations of 
Ag+ ions (0.00 – 1.20 µM).  Embryos were carefully monitored post-treatment at 24, 48, 
72, 96, and 120 hpf (Figure 11).  We examined the abnormalities in developing embryos 
at each treated stage.  Many morphological defects were observed in the developing 
embryo, which included abnormal finfold and tail development, cardiac malformation, yolk 
sac edema, and head and eye abnormalities, as recorded in Figure 13. 
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Figure 12: Study of concentration and stage dependent toxic effects of AgNO3 on 
embryonic developments.  
Histograms show the average number of staged embryos (A-E; stages I – V), incubated 
with given concentrations of AgNO3 for 2 h, that developed into normal or deformed 
zebrafish or died in egg water over 120 hpf.  The means and standard deviations (error 
bars) of the number of embryos shown for each given concentration are from triplicate 
measurements.  
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Table 2: Critical Ag+ ion Concentration for Specific Developmental Stages of 
Zebrafish. 
Stage I II III IV V 
Critical Concentrations (µM) >0.1 µM 0.2 µM 0.4-0.8 µM 0.8 µM 0.8 µM 
 
 
All stages presented some abnormal developing embryos.  The shared common 
type of abnormality amongst all stages was finfold abnormalities, which typically affects 
the median finfold region (Figure 13A (a)).  In a normally developing embryo, the median 
of the finfold is clear and organized thing membrane around the trunk region which 
contains unsegmented fin rays.  However, in the abnormal finfold region, we observed 
that the tissue is disorganized and the structure is altered.  In the more severe deformed 
embryos, the fin rays are severely misshaped and the shambolic.  We also observed tail 
and spinal cord flexures in most of the deformed embryos from all stages (Figure 13A 
(a)).  In normally developed embryos, the tail and spinal cord will develop straight to the 
posterior-most tip of the tail.  However, in those embryos treated with Ag+ ions, the tail 
was often curved or flexed.  In some more severe cases, the tail was extremely truncated 
compared to normally developed embryos.  These severities in the tail flexure usually 
resulted from increased Ag+ ion concentrations.   
Severity and other forms of observed deformities usually depended on the treated 
developmental stage.  Embryos treated with higher Ag+ ion concentrations in all stages 
usually resulted in edema in the pericardial sac, the double-layered conical sac of fibrous 
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tissue which surrounds the developing heart muscles. In normal embryos, the pericardial 
sac is a thin membrane serving as a protective barrier to the developing heart.  However, 
observed swelling of this region resulted in enlargement of the heart muscles.  
Additionally, enlargement of the yolk sac region was also observed.  The yolk sac region 
is a bulbous area containing nutrients needed for the developing embryo, which will 
usually shrink during the development, as the embryo becomes less depended on those 
nutrients.  We, however, observed this region to be swollen after 120 h of treatment with 
the Ag+ ions.   
In the most severe cases, we observed head and eye abnormalities in those 
embryos treated with Ag+ ions.  In these cases, we observed smaller or irregularly we 
observed either one or both lenses were altered.  These cases were rarely observed, but 
when present, was usually together with the other observed abnormities previously 
mentioned.   
Figure 13 shows the represented deformities shown in all treated stages.  In 
embryos treated in all stages, we observed all of the described abnormities (Figure 13 (a-
d)) with the finfold and tail flexures being common for the treated concentrations, where 
most were found in the 0.10 and 0.20 µM treatment groups.  For stages, I, II, and III, yolk 
sac and pericardial sac edemas were commonly found in the 0.20 – 0.40 µM treatment 
groups.  In stage IV we observed pericardial sac edemas and yolk sac edemas in all 
treated groups.  In stage V, although rarely observed, we only saw the presence of all 
categorized abnormalities in the higher concentrations. 
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Figure 13: Representative optical images of deformities observed in stages I – V 
after acute treatment with AgNO3.  
(A) Stage I, (B) Stage II, (C) Stage III, (D) Stage IV, (E) Stage V represents  deformed 
zebrafish displaying (a) finfold abnormality; (b) tail/spinal cord flexures; (c) pericardia 
malformation and yolk sac edema; (d) head and eye abnormality.  (F) Represents 
normally developed Zebrafish larvae at 120 hpf.  (G) Represents dead embryo after 
treatment.  Scale bar: 250 µm. 
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shaped of tissues where defined craniofacial anatomy was clearly observed.  The eyes 
would become smaller in size compared to a normally developed embryo.  In minor cases,  
In stage III, we did observe more severe cases of tail curvatures and spinal cord 
infractions in those higher concentrations of the Ag+ ions.  This is significant in that stage 
III is the early segmentation stage where the notochord and spinal cord are forming.  The 
phenotypes observed suggest that exposure to the Ag+ ions at this developmental stage 
is highly influenced to result in tail malformation.  Likewise, in stage IV, pericardial sac 
edemas were prominent in all treated concentrations.  These observed results suggest a 
phenotypical depended occurrence in developing embryos when Ag+ ions are present.  
Possible reasons for the high dependence of type and severity of defects on the stage of 
development and concentration of Ag+ ions could be due to the following: (i) Ag+ ions 
enter inside the chorion space of the embryo during the specific stage of development 
and affect the specific proteins, signaling, and developmental pathways during that period 
of development. (ii) An increase in the number of Ag+ ions inside the chorion space of the 
embryo during the specific stage of development increases the altering effects of the 
protein, signaling, and developmental pathways during development increasing severity 
of the deformity observed or death.  
Our results describe a range of developmental defects and absolute death 
following exposure of developing zebrafish embryos to micromolar concentrations of Ag+ 
ions at particular embryonic stages of development.  Specific developmental pathways of 
embryonic development are still unknown, such as, differentiation into specialized tissues 
and organs, specifically how cells communicate with each other, how they become 
committed to a certain fate, and how they formulate a pattern to become a structure.  18, 
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73, 74  Stage-dependent developmental responses to Ag+ ions, shown here, in a 
concentration-dependent manner, demonstrates the possibility of being able to pick 
specific developmental pathways to create particular phenotypes and as potential 
developmental therapeutic agents to treat specific disorders and generate specific 
developmental mutation in zebrafish, by alteration of the time of application of the Ag+ 
ions. 
Study of stage-dependent effects of Ag+ on embryonic cardiac development  
As we observed pericardial sac edema and cardiac malfunctions in zebrafish treated with 
silver ions, we further studied the effects of these ions on the cardiac function of zebrafish 
after their exposure to the Ag+ ion compared with the controls at different  time points.  
Basically, individual myocardial cells begin to contract irregularly around the 22-somite 
stage (21 hpf) giving heart rate at about 25 beats per minute. Heart rates dramatically 
increase to about 90 beats per minute by 24 hpf when shortly thereafter blood circulation 
begins.  As the heart developed, morphological differentiation progresses in an arterial to 
venous direction. The heart tube has looped and beat at higher rates to provide a strong 
circulation to the trunk and head.  75, 76 
In all stages, we found that the number of embryos with normal developed heart 
decreased as the Ag+ ion concentration increased since some embryos exposed to Ag 
ions were either dead or deformed. In normally developed zebrafish, heart rates 
increased as the heart developed. Heart rates of normally developed zebrafish at 48 hpf 
and 120 hpf were significantly greater than those at 24 hpf when the heart was at the 
early developmental stage (Figure 14). However, Ag+ ions insignificantly reduced embryo 
heart rates at 24, 48, and 120 hpf in a dose-dependent manner (Figure 14). In contrast, 
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those cardiac deformed zebrafish at all concentrations surprisingly showed no significant 
difference in heart rates over developmental periods. Their heart rates at 48 hpf and 120 
hpf were at the same or lower than those at 24 hpf (Figure 14). This suggests that the 
heart became increasingly deformed over time which could lead to lower heart rates, less 
blood flow, and oxygen supply, and thus possibly contributing to mortality. Ag NPs have 
previously shown to interfere with regular cardiac functions.44, 64, 77-79  Improper blood flow 
could starve the cells of gases and essential nutrients, resulting in cell death.74, 80, 81 
It is worth noting that the heart rates of cardiac deformed zebrafish were much 
lower than zebrafish with normal cardiac development but not in a concentration-
dependent manner. Although the mechanisms are still not well understood, Ag+ ions could 
disrupt heart development contributing to heart deformities and then leading to the 
depressed heart rates.  
Specifically, we did not observe a significant difference between treated stages, as 
all stages displayed similar heart rates, despite the differences in overall development 
and toxicity, which showed a stage-dependent trend.  Stage I – V (Figure 14 A-E) all 
resulted in similar trends, where, the higher the Ag+ ion, the lower the heart rate recorded.  
One notable difference we did observe was for stage IV (Figure 14 D) when it came to 
those deformed zebrafish in the 1.20 µM treatment group.  The heart rate for the deformed 
embryos was noted to be significantly higher at 120 hpf.  This could be influenced by 
treatment at this particular developmental stage, where cardiogenesis is majorly affected 
during the development of the heart muscles.  More studies would need to be conducted 
to further examine this phenomenon.   
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Figure 14: Quantitative Heartbeat Analysis for specific developmental stages of 
embryos.  
Heartbeats were taken at 24, 48, and 120 hpf for all embryos.  Based on development, 
heartbeats per minute was graphed by concentration for (a) 24 hpf Normal, (b) 24 hpf 
Deformed, (c) 48 hpf Normal, (d) 48 hpf Deformed, (e) 120 hpf Normal, and (f) 120 hpf 
Deformed Analysis for (A) Stage I embryos, (B) Stage II, (C) Stage III, (D) Stage IV, (E) 
Stage V.  
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Study of stage-dependent hatched time of zebrafish upon Ag+ concentration 
Zebrafish hatching is a vital step for survival. Longer hatching duration could leave 
organisms to more susceptible to predators and if hatching is inhibited, embryos could be 
die in their chorions.  14, 82  In fact, zebrafish hatching is associated with two processes.  
16, 20, 22 Initially, the hatching enzyme from the hatching gland is released to break down 
the inner vitelline envelope of the cellular chorion, and then the movement of the embryo 
breaks the weaken chorion 39. Delayed hatching in response to Ag NP exposure has been 
reported. For example, zebrafish had delayed hatching after exposure to 1 µM Ag NPs. 
However, the occurrence of delayed hatching due to Ag+ ion exposure in zebrafish has 
not yet been widely studied.   
We studied the concentration-dependent effects of Ag+ ions on the hatching time 
of zebrafish embryos (Figure 14) for each developmental stage. Embryos were exposed 
to Ag+ ions with various concentrations (0-1.2 µM) in egg waters for 120 hr. The 
developing zebrafish embryos were imaged and we monitored newly hatched embryos 
over time at 4, 24, 48, 72, 96, and 120 hpf. The numbers of newly hatched embryos are 
shown in Figure 9 for stages I - V. Embryos started to hatch at 48 hpf and the majority of 
them hatched at 72 and 96 hpf. In all stages, the hatching of embryos was significantly 
delayed by Ag+ ion exposure in a concentration-dependent manner. The embryos that 
were exposed to higher concentrations of Ag+ ions had hatched later than the control and 
those exposed to the lower Ag+ ion concentrations. For example, as shown in Figure 14A, 
in stage I, at 72 hpf, the majority of control embryos hatched and the numbers of hatched 
embryos decreased as the concentration increased while at 96 hpf, majority of the 
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embryos exposed to low Ag ion concentrations (0.05 and 0.10 µM) hatched and at 120 
hpf, most of the embryos exposed to high Ag+ ion concentrations (0.20-1.2 µM) hatched.  
In stage III - V treated embryos, we observed a significant number of embryos 
started to hatch at 60 hpf, which differs from stage I and II.  This suggests that this 
developmental time point results in treated embryos being less sensitive to the Ag+ ions 
upon hatching.  This difference may suggest that when treated at earlier developmental 
stages, hatching is reasonably delayed to later time points when Ag+ ions are present, 
exhibiting a stage dependent effect on hatching.   
Mechanisms of Ag ions causing delayed hatch is still unclear. The delay possibly 
associates with slowing maturation of the hatching grand, inhibition of hatching enzyme 
and stunted growth and movement. Notably, zebrafish contains two zinc-based matrix 
metalloproteinase enzyme genes (ZHE1 and ZHE2) and gene duplication events and 
subsequent mutations lead to extremely low expression of ZHE2 and non-functioning of 
hatching. Interestingly, a study showed that Ag+ ions did not interfere with ZHE1 activity 
suggesting that the hatching delay could result from another injury mechanism.39, 68 
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Figure 15:  Rate of Hatched Zebrafish Exposed to Ag+ ions at specific 
developmental stages.   
The overall hatching rate of embryos were taken at 48, 60, 72, 96, and 120 hpf.  Hatching 
was reported by dilution of treated (a) 0.00 µM, (b) 0.10 µM, (c) 0.20 µM, (d) 0.3 µM, (e) 
0.40 µM, (f) 0.80 µM, and (g) 1.2 µM AgNO3 for (A) Stage I embryos, (B) Stage II, (C) 
Stage III, (D) Stage IV, (E) Stage V.   
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SUMMARY 
In summary, we have studied the toxicity of Ag+ ions on zebrafish embryos in vivo 
at specific stages of development, aiming to assess nanotoxicity on embryonic 
development, heart functions, and hatch time. Concentration-dependent, as well as 
stage-dependent, toxic effects of the Ag+ ions on embryonic development, were 
observed, showing that the number of zebrafish developed normally decreased while the 
number of dead zebrafish increased as Ag+ ion concentrations increased. We observed 
a phenotypical dependence of abnormal development upon developmental stage when 
exposed to Ag+ ions.  Many morphological defects were observed in the developing 
embryo, including yolk sac edema, abnormal finfold and tail development, and cardiac 
malformations at each stage of development, corresponding to the stage of treatment.  In 
general, the number of different types of defects and the severity of each varied with the 
stage of treatment and increased with increasing concentration of Ag+ ions demonstrating 
the possibility of selectively targeting specific embryonic developmental pathways by 
altering the stage of development and dose of NPs for developmental therapeutic studies. 
The Ag+ ions not only interfere with embryonic development but also heart development 
and functions. We observed heart deformities and lower heart rates in zebrafish exposed 
to Ag+ ions. Additional studies are necessary for elucidating the mechanism of Ag+ ion 
induced heart deformities. Moreover, delays hatching in zebrafish were observed in a 
dose-dependent manner. Zebrafish embryos exposed to high concentrations of Ag+ ions 
hatched later.  The investigation of biocompatibility of silver ions, in comparison to the 
study of metal and metal oxide nanomaterials in specific stages of development of 
embryos can offer new knowledge about the developmental processes and environment, 
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and provide new insights into the mechanics of the developing embryo as well as aid in 
the finding for functional nano-developmental treatments for various disorders in early 
development. The study of nanomaterials, as well as their bulk counterparts, can lead to 
understanding their mechanism of toxicity, which is needed since they are increasingly 
used in many areas of biomedical research. 
MATERIAL AND METHODS 
Breeding of zebrafish embryos 
Wild-type adult zebrafish were housed in a stand-alone system (Aquatic Habitat). 
They were maintained and bred as described previously. Briefly, we placed two pair 
adults zebrafish in a clean 10-gallon breeding tank and used a light (14 h)-dark (10h) 
cycle to trigger breeding and fertilization of embryos. We collected embryos at 2 hpf, 
transferred them to a Petri dish, and well-rinsed them with egg water to remove 
surrounding debris. The washed embryos were then used for the study of dose-
dependent toxicity of Ag+ on embryonic development.  All experiments involving embryos 
and zebrafish were conducted in compliance with IACUC guidelines (protocol # 15-012). 
Treatment and monitoring of zebrafish embryos 
  Embryos were collected and transferred into a petri dish containing egg water 
(1.2 mM NaCl), washed twice with egg water to remove the surrounding debris, and 
placed into 48-well plates with each well containing one embryo in egg water.  Sixteen 
embryos were tested per concentration, per stage of development; each experiment was 
repeated 3 times, totaling 48 embryos analyzed per concentration, per stage of 
development.  Treatment for each developmental stage is for 2 h, followed by a wash with 
egg water, then placed in new wells for remaining of development.  Embryos were directly 
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imaged by bright-field optical microscopy using an inverted Zeiss Axiovert microscope 
equipped with a 4x objective, CCD (Coolsnap, Roper Scientific) and a digital color camera 
(Sony). 
Study and characterization of toxicity of Ag+ on embryonic development 
To study the concentration-dependent effects of Ag+ ion on embryonic 
development, a dilution series of Ag+ ion treatment solutions (0, 0.10, 0.20, 0.30, 0.40, 
0.80 and 1.20 µM) were incubated acutely with 5 stages of embryos in egg water for 2h.  
Each experiment was carried out at least 3 times and a total number of embryos at 48 
was studied for each individual concentration to gain representative statistics.  Ag+ ion 
concentrations were calculated to correspond to previous studied Ag NPs studies.  
Embryos in egg water in the absence of Ag+ ion and in the presence of supernatant were 
placed in 48-well plates as control experiments to probe the effects of possible trace 
chemicals from NP synthesis.  The embryos in the 48-well plates were incubated at 
28.5C, and directly observed at room temperature using an inverted Zeiss Axiovert 
microscope equipped with a digital color camera at 24, 48, 72, 96, and 120 hpf. 
Data analysis and statistics 
For the study of dose-dependent effects of NPs on embryonic development, a total 
number of 48 embryos were studied for each NP concentration and each control 
experiment over 120 hpf with a minimum of 12 embryos studied in each measurement.   
We presented averaged the number of normally developed, dead and deformed zebrafish 
vs. Ag+ concentration with standard deviations.  We used conventional statistical analysis 
methods (t-test, ANOVA, Tukey’s, SPSS Statistics with P = 0.05) to determine the 
significance of the different observations between all concentrations for development, 
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hatching, and heartrate results.  A Pairwise T-test comparison was performed of 
Deformities Histogram. 
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CHAPTER IV 
STUDY OF STAGE DEPENDENT BIOCOMPATIBILITY AND TOXICITY OF SINGLE 
42 NM SILVER NANOPARTICLES USING EARLY DEVELOPMENT OF ZEBRAFISH 
EMBRYOS 
INTRODUCTION 
Nanoparticles (NPs), per their small size and unique physical properties, are ideal 
for use in probing the nanoscale environments of living organisms, which enables the 
study of a developing living organism at specific developmental stages of embryonic 
development.72, 83-86  Single nanoparticles and their unique optical properties make 
imaging in vivo more sensitive, allowing the transport of the NP in living vertebrates to be 
monitored and offers new information on the developing mechanisms of the embryonic 
organism.  NP probes can be used in a variety of applications for new insight into 
developmental processes, such as the improvement of screening tools in developmental 
biology to investigate the embryonic innermost environment, to potentially control and 
regulate certain processes in development, and to target specific system regulators for 
biomedical biological uses.  Nanomaterials could demonstrate developmental stage-
dependent requirement of phenotypical morphology induced, suggesting that the 
nanomaterials, at higher concentration, may interact with target developmental pathways 
of interest.43, 64, 77, 87-89  In this study, we used our previously described nanomaterials,44 
Ag NPs, and our effective embryo developmental model system, zebrafish embryos, to 
focus on acute developmental stage-dependent biocompatibility and understand the 
impact of nanomaterial exposure during embryogenesis and their mechanisms to induce 
toxicity at specific development periods. 
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Commonly, fluorescent probes have been used for probing and imaging in vivo 
cellular pathways during embryonic development.90  However, using fluorescent probes 
have their limitations because they will undergo photodecomposition, which limits the time 
for intrusive analysis of the embryonic environment for specific stages of interest in real-
time.  Nanomaterials, such as quantum dots (QDs) and noble metal NPs (Ag, Au and 
their alloys), are being used more as sensors for in vivo assays because they offer unique 
properties that make them ideal for imaging.45, 47, 91-94  Though QDs have unique optical 
properties compared to their fluorescent counterparts, they still experience a certain 
extent of photodecomposition which still introduces a sense of variance from real-time 
analysis. 
Ag NP probes have unique optical properties over many fluorescent imaging 
approaches because they have localized surface plasmon resonance (LSPR), enabling 
characterization of their size and shape, and they offer high quantum yield (QY) of 
Rayleigh scattering making them bright and easy to see using dark-field optical 
microscopy and spectroscopy (DFOMS).60, 95-97  Ag NPs can be used as a probe for real-
time study over an unlimited period of time because they do not experience 
photodecomposition as fluorescent beads can.  In addition, the LSPR spectra, or color of 
the Ag NPs, can be used to show size-dependence.60, 95, 96  Using the LSPR spectra of 
the multicolor Ag nanoparticles it is possible to be able to directly characterize the uptake 
and diffusion of the same color nanoparticle at the nanometer scale in real-time, in 
different biological environments based on using the same sized Ag NPs.93, 98, 99 
Zebrafish (Danio rerio) have been extensively employed as a well-studied 
vertebrate model for embryological development because of its small size, its short 
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breeding cycle, and the wealth of information available for manipulation.63, 70, 100-102  Its 
transparency throughout development allows observation of all internal organ 
development from outside the chorion without disturbing the living embryo.  Zebrafish are 
time efficient for care and maintenance and they effortlessly spawn in large numbers from 
week to week producing macroscopic fertilized eggs, which are ideal for observing 
different developmental stages.  The embryonic development is so rapid that the first 
stages of development are completed in the first 24 hours post fertilization (hpf) and the 
normal embryo will hatch and swim by 72 hpf.  The majority of developmental mutations 
identified in zebrafish have close counterparts in other vertebrates, suggesting that this 
system can be effectively used as a model for understanding the developmental 
processes of higher organisms, including humans.66, 103  Therefore, zebrafish embryos 
offer a unique opportunity to investigate developmental processes upon treatment with 
NPs to investigate stage dependence NP effects on embryonic development. 
Zebrafish have been used as a model organism for many chemical-screening and 
drug studies, however, the acute biocompatibility on different zebrafish developmental 
stages is not well studied.101, 104  The acute biocompatibility of Ag NPs on specific 
sensitive stages of embryonic development has, to our knowledge, only been attempted 
by our previous studies with smaller sized nanoparticles.  It is important to explore the 
biocompatibility of Ag NPs acutely at specific stages of embryonic development to access 
the ability of Ag NPs to be used for in vivo imaging at any embryonic stage of development 
as well as probes in real-time to explore the changing embryonic environment during 
development, including cardiac influences and neurological changes. 
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  In this study, we have designed in vivo assays to study the biocompatibility of Ag 
NPs in embryonic development to probe developmental changes that could help aid in 
the investigation of molecular mechanism altered during nanoparticle exposure.  We used 
imaging assays and quantitative cardiac studies to probe the effects on zebrafish 
embryos.    
RESULTS AND DISCUSSION 
Synthesis and characterization of Ag nanoparticles (NPs)  
We used our previously developed sphere-shaped silver-based nanoparticles that 
were washed and purified to study their interactions and biocompatibility with key stages 
in developmental biology.  Thus, we can determine Ag NPs role in developmental 
processes, including stage dependent and dose-dependent morphological responses, for 
their potential  use as developmental targeting probes for biomedical applications.44  We 
characterized the stability, size and optical properties of the purified Ag NPs in egg water 
embryo media (1.2 mM NaCl) for 120 h using UV-vis absorption spectroscopy, dark field 
optical microscopy and spectroscopy (DFOMS) and high resolution transmission electron 
microscopy (HRTEM). 
We characterized the size of the Ag NPs using HRTEM and the size was with an 
average diameter of 41.5 ± 7.6 nm (Figure 16).  A representative optical image of Ag NPs 
in Figure C illustrates that the majority of NPs appear to be blueish green to green, with 
a few reds.  These results suggest that Ag NPs are uniform in size and shape based on 
their color (LSPR).  The representative LSPR spectra of single blue, green and red Ag 
NPs with peak wavelengths (λmax) at 498 nm (blue) (FWHM = 38 nm), 554 nm (green) 
(FWHM = 47 nm), and 659 nm (red) (FWHM = 47) nm, respectively (Figure 16).  Thus, 
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the color of Ag NPs can be used as size index to directly distinguish and determine the 
size of NPs using DFOMS, even though the size of NPs cannot be directly measured due 
to the optical diffraction limit. We characterized the stability of Ag NPs in egg water for 
120 hours, which is the length of embryonic studies.  The results are given in Figure 17.  
The absorbance spectra of freshly prepared and purified Ag NPs before and after the 
incubation time with egg water demonstrated a peak wavelength (λmax) at 401nm (FWHM 
= 56 nm) and remained unchanged for 120 hours (Figure 17 A).  We found that the 
number of NPs remained relatively unchanged when incubated in egg water for 120 h, 
where the average of total number of NPs from triplicate runs at 0 h and 120 h is 2,044 ± 
28, and 1,979 ± 12, respectively The unchanged number of NPs and stable absorbance 
spectra indicates that the Ag NPs are very stable in egg water media and remain non-
aggregated. 
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Figure 16: Characterization of sizes, shapes, and plasmonic optical properties of 
single Ag NPs.   
(A) HRTEM image shows the spherical shape of single NPs. (B) Histogram of size 
distribution of single NPs determined by HRTEM shows average diameters of 41.5 ± 7.6 
nm. (C) Dark-field optical image of single NPs shows that a majority of NPs are plasmonic 
green with some blue-green and red. (D) LSPR spectra of representative single NPs. 
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Figure 17: Characterization of stability of Ag NPs in egg water (CNPs = 0.5 nM) for 
120 h. 
(A) UV-Vis absorption spectra of the NPs dispersed in egg water at 28.5 °C for (a) 0 and 
(b) 120 h show that its peak absorbance of 401 nm (FWHM = 56 nm) remains unchanged 
for 120 h. (B) The average of total number of NPs from triplicate runs at 0 and 120 h is 
2,044 ± 28, and 1,979 ± 12, respectively. The 10 images are acquired at each given time 
point using DFOMS. 
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Exposure of Ag NPs to specific developmental stages of zebrafish embryos 
Imaging and monitoring live animals throughout development provides a more 
informative view of these biological events.  That is why we selected zebrafish embryos 
to serve as our animal model.  Danio rerio embryos are prominent animal models for real-
time analysis during embryogenesis.15, 21, 105  In fact, zebrafish have several noteworthy 
advantages for live animal imaging in real time. Foremost, both adult and young zebrafish 
can be easily maintained for imaging applications. Secondly, zebrafish are optically 
transparent during early development and, as a result, optical imaging techniques can be 
easily applied. Thirdly, zebrafish fertilization is external, which enables live animal 
imaging during all stages of embryonic development. Finally, zebrafish have a high 
homology with mammals.  Having these genetic similarities allows for complex 
investigation to study those can be used to model biological defects that occur in higher 
animals. 
The normal course of embryonic development in zebrafish in the absence of NPs 
for each acute treatment stage is depicted in Figure 18.  Acute treatment occurred at five 
different stages of development for a 2 h incubation time with NPs: stage I, cleavage 
stage (2-4 hpf) (Figure 18 A), stage II, gastrula stage (6-8 hpf) (Figure 18 B), stage III, 
early segmentation stage (12-14 hpf) (Figure 18 C), stage IV, late segmentation stage 
(21-23 hpf) (Figure 18 D) and stage V, hatching period (48-50 hpf) (Figure 18 E).  The 
stages were determined by choosing critical events in embryonic development for 
studying molecular mechanisms from exposure with NPs.  During stage I, embryos 
undergo dramatic changes like rapid cellular division and embryonic pattern formation.61, 
106  During stage II, embryos undergo cell movements and migration and establishment 
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of the early organ systems.  In stage III, embryos begin somitogenesis and notochord 
formation, which is important for proper development of the axial skeleton, the vertebrate 
spinal column, and the skeletal muscle.39, 68, 69  During stage IV, embryos undergo 
development of the circulatory system and the heart is being formed.39, 68, 104  During stage 
V, the embryo is in the hatching stage and finishing its development.   
Danio rerio embryos exposed to a series concentrations of Ag NPs acutely at 
select stages revealed that NPs induced death, as well as a variety of morphological 
defects and the number of different types of defects and the severity of each increased 
with increasing concentration of NPs.  Results of overall morphology are presented in 
Figure 19.  Stage I resulted in an increasing percentage of deformities in Ag NP treated 
embryos as the concentration was increased (Figure 18 A) with a critical concentration at 
0.10 nM.  This stage appeared sensitive to the treatment with NPs causing death of the 
embryos.  In stage I, exposure to the lowest concentration even produced a small 
percentage of abnormalities and death.  At higher concentrations, an increasing 
percentage of Ag NP treated embryos died; correspondingly, recovery of viable 
abnormalities also declined.  At the highest tested concentration, a majority of embryonic 
death was observed (Figure 19 A).   
Embryos treated in stage II had a high rate of death but showed a low number of 
deformities (Figure 19 B), correlating with increasing NP concentration and having a 
critical concentration at 0.20 nM.  This stage also appeared sensitive to the treatment with 
NPs causing death of the embryos.  This was specific for this stage of development and 
most likely due to the fact that during this stage of development the embryos are 
undergoing vast cellular movements and formation of the early organ systems.107, 108  
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During this period the germ layers of the embryos are also being established.107, 108  Stage 
II of development is a time when the onset of gene expression is starting and cell 
migration is prominent.  Exposure of the Ag NPs could affect the pathways during 
development causing an increase in death at this stage, which is directly related to the 
increase in the NP concentration.  
Stage III resulted in an increasing number of embryonic death as the concentration 
was increased (Figure 19 C) with a critical concentration is between 0.20 and 0.50 nM.  
Exposure to the lowest concentration in stage III produced small quantities of 
abnormalities.  At the highest tested concentration, a total embryonic death was observed 
(Figure 19 C). 
Stage IV treated embryos resulted in increased deformities with the lowest 
concentration and remained consistently constant throughout Ag NP concentration rises 
(Figure 19 D).  The critical concentration was determined to be 0.20 nM.  In stage IV even 
exposure to the lowest concentration produced abnormalities.  At higher concentrations, 
a small increasing percentage of Ag NP treated embryos died.  At the higher tested 
concentrations in stage IV, a majority of embryonic death was observed (Figure 19 D).   
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Figure 18: Normally developed zebrafish at stages I – V at the time of acute 
treatment and observations after acute treatment.   
Representative optical images of normally developed zebrafish at the time of acute 
treatment for stage I – V, (a) 2 hpf (cleavage stage); (b) 6 hpf (early gastrula stage); (c) 
12 hpf (early segmentation stage); (d) 21 hpf (late segmentation stage) and (e) 48 hpf 
(hatching stage).  Scale bar = 500 µm. 
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Figure 19:  Histograms displaying the distribution of effects resulting from 
treatment with Ag NPs and the supernatant on zebrafish.  
(A) Normally developed, deformed, and dead zebrafish vs. concentration of Ag NPs in 
stage I.  (B) Normally developed, deformed, and dead zebrafish vs. concentration of Ag 
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NPs in stage II.  (C) Normally developed, deformed, and dead zebrafish vs. concentration 
of Ag NPs in stage III.  (D) Normally developed, deformed, and dead zebrafish vs. 
concentration of Ag NPs in stage IV.  (E) Normally developed, deformed, and dead 
zebrafish vs. concentration of Ag NPs for stage V.  (F) Normally developed and dead 
zebrafish vs. concentration of supernatant removed from Ag NP washing.   
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Stage V resulted in no morphological defects and only a slight increase in the death 
rate (Figure 19 E) with a critical concentration between 0.20 nM and 0.50 nM.  This is 
possibly due to that during stage V, the embryo is in the hatching stage and finishing its 
development.108  Untreated control embryos for stages I through V (0.00 nM) produced 
no abnormal embryos and embryo viability was within normal limits (Figure 19 A-F).  
Control embryos exposed to (nanoparticle-free) supernatant from the NP washing 
process showed minimal levels of toxicity at all tested concentrations (Figure 19 F). 
The effective dose for our acute studies was determined from our previous chronic 
studies.42, 44, 64, 77, 78, 88, 109  We treated stage I through V embryos acutely with various 
concentrations of Ag NPs (0.00 – 0.50 nM).  Embryos were carefully monitored post-
treatment at 24, 48, 72, 96, and 120 hpf.  We examined the defects associated with the 
treatment of developing embryos with Ag NPs at each treated developmental stage.  
Many morphological defects were observed in the developing embryo, including abnormal 
finfold and tail development, cardiac malformation (pericardial sac edema), yolk sac 
edema, and head and eye abnormities as shown in Figure 20.  Every treated stage 
presented some abnormalities.  The shared abnormality among stages I, II, IV, and V 
treated embryos was finfold abnormalities, typically affecting the median finfold region 
(Figure 20 A, B, D, E (a)).  In normally developing embryos, the median finfold area is a 
clear, thin membrane around the entire trunk region containing unsegmented fin rays.  65, 
69  In treated embryos at these stages, the tissue structure of the finfold was disorganized 
and in the more severe cases, the shapes of the finfold and the developing fin rays were 
altered.   
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Treated embryos from stages I, II, III, and V displayed as another common defect, 
an abnormal tail (spinal cord) flexure phenotype (Figure 20 A-C, E (b)).  This defect was 
often accompanied by tissue abnormalities of the finfold.  In normal developing embryos, 
the notochord and spinal cord develop straight to the posterior-most tip of the tail.  In the 
treated embryos for these stages, however, the tail region was flexed to some extent.  In 
the more severely flexed embryos, the flexure was extreme and the overall length of the 
tail was reduced (Figure 20 C (b)).  The tail flexure defect also increased in severity with 
increasing NP concentration.    
Another commonly shared defect, which was presented in all stages, was 
presented as a cardiac malformation.  More specifically, we observed swelling of the 
housing membrane where the ventral and artery bulbs develop and starts pumping, 
resulting in pericardial sac edema.  In contrast to normal embryos, in the stage I treated 
embryos; the pericardial sac region was swollen and enlarged (Figure 20 A-E (c)).  In 
severe cases, the pericardial sac was extremely large and the cardiac ventricle was 
decreased in size.   
Yolk sac edemas were readily observed in stages II, IV, and V (Figure 20 B, D-E 
(d)).  In normally developing embryos, the yolk sac region is a bulbous area containing 
yolk that provides nutrients to the developing embryo and during the later developmental 
process, the yolk sac shrinks.  In the affected treated embryos of these stages, however, 
the yolk sac region was swollen and enlarged.  This type of edema is a common defect 
in treated embryos.  It is thought that the dependence of the nutrients during treatment 
blocks those enzymes responsible for decreasing this area.61, 63, 104, 110  Similar to our 
previous studies and treatment with both Ag NPs and Ag+ ions, we see this type of defect 
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combined with another type of deformities, normally, finfold abnormities and pericardial 
sac edemas.  This leads us to believe that this lack of shrinkage in an area important for 
embryo survivability is highly influenced by the development of other major organs in the 
zebrafish.  If certain areas are not properly developed and outside nutrients cannot be 
sought by on the embryo’s own, then the yolk sac will continue to serve as the embryos 
main source of nutrients during development.    
In stages III – V, we observed head and eye abnormalities (Figure 20 C-E (e)).  
The heads of these abnormal zebrafish were smaller than, and not as round as, a normal 
embryo would appear (Figure 20 F).   
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Figure 20: Representative optical images of deformities observed at 120 hpf in 
stages I – V after acute treatment with Ag NPs.  
 Optical images of deforms observed :(a) finfold abnormality; (b) tail/spinal cord flexure; 
(c) pericardial sac edema; (d) yolk sac edema and (e) head and eye abnormities.  Stage 
I (A), Stage II (B), Stage III (C), Stage IV (D), and stage V (E) images represent common 
deformed found in each stage. (F)  Normally Developed zebrafish.  Scale bar = 500 µm.     
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A histogram of the average number of embryos observed with different types of 
deformities at each stage for treated Ag NPs concentrations is presented in Figure 21.  
Here, we see that in stage I, the lowest Ag NP concentration, 0.02 nM, presented only 
pericardial sac edemas, whereas 0.10 and 0.20 nM treatment groups presented tail 
flexures and yolk sac edemas (Figure 21 A).  For stage II, the lowest treated concentration 
of Ag NPs where deformed zebrafish were observed was 0.05 nM.  At this concentration, 
only finfold abnormality was recorded.  The higher concentrations all resulted in tail 
flexures, pericardial sac edema, and/or head abnormality (Figure 21 B).  For stage III, we 
observed the most abnormal zebrafish from lower concentration groups, where multiple 
defects were recorded for 0.02 and 0.05 nM (Figure 21 V).  This, as a result, was the 
most sensitive stage for this particular size of NPs.  Stage IV presented few defects only 
observed in the 0.10 and 0.20 nM treatment groups (Figure 21 D).  Stage V, the hatching 
stage, interestingly enough, presented many different types of deformities in the higher 
treated concentrations (Figure 21 E).  This is significant because, in other stages, these 
type of deformed zebrafish did not survive in the higher treated group (0.20 and 0.50 nM).  
The fact that these deformed zebrafish were able to survive after exposure is a manner 
that needs to be further explored. 
Possible reasons for the high dependence of type and severity of defects on the 
stage of development and concentration of NPs could be due to the following: (i) The NPs 
enter inside the chorion space of the embryo during the specific stage of development 
and affect the specific proteins, signaling, and developmental pathways during that period 
of development. (ii) An increase in the number of NPs inside the chorion space of the 
embryo during the specific stage of development increases the altering effects of the 
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protein, signaling, and developmental pathways during development increasing severity 
of the deformity observed or death. Our results describe a range of developmental defects 
and absolute death following exposure of developing zebrafish embryos to nanomolar 
concentrations of Ag NPs at particular embryonic stages of development.  Specific 
developmental pathways of embryonic development are still unknown, such as 
differentiation into specialized tissues and organs, specifically how cells communicate 
with each other, how they become committed to a certain fate, and how they formulate a 
pattern to become a structure.107, 110  Stage-dependent developmental responses to Ag 
NPs, shown here, in a dose-dependent manner, demonstrates the possibility of being 
able to pick specific developmental pathways to create particular phenotypes and as 
potential developmental therapeutic agents to treat specific disorders and generate 
specific developmental mutation in zebrafish, by alteration of the time of application of the 
NPs. 
Quantitative heartbeat study of zebrafish upon Ag NPs concentration  
As we observed pericardial sac edema and cardiac malfunctions in zebrafish treated with 
Ag NPs during all stages of treatment, we further studied effects of Ag NPs on cardiac 
functions of zebrafish after their exposure to NPs compared with the controls at three 
different time points: 24 hpf (early heart formation period); 48 hpf (embryo hatching 
period); and 120 hpf (full development period). We plotted the average heart rate per 
minute for all treatment groups at each stage (line plots), along with the total number of 
zebrafish analyzed (bar plots) (Figure 22 A-E).  Essentially, individual myocardial cells 
begin to contract irregularly around the 22-somite stage (21 hpf) giving heart rate at about 
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Figure 21: Histograms of the types of deformities concentration of Ag NPs 
treatment in zebrafish.   
Deformities type was plotted for each developmental stage; Stage I (A), Stage II (B), 
Stage III (C), Stage IV (D), and stage V (E) images represent common deformed found 
in each stage. 
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40-45 beats per minute. Heart rates dramatically increase to about 70-80 beats per 
minute by 24 hpf when shortly thereafter blood circulation begins. 111 As the heart 
develops, morphological differentiation progresses in an arterial to venous direction. The 
heart tube has looped and beats at higher rates to provide a strong circulation to the trunk 
and head. 111  Around 48 hpf, the observed normal beating heart of a zebrafish will roughly 
be around 120 beats per minute.  At 120 hpf, the will slightly increase in normal zebrafish 
to roughly 150 beats per minute and will remain around this average until adulthood.   
We found that the number of embryos with normally developed heart decreased 
as the Ag NP concentration increased, resulting in a dose-dependent manner.  In 
normally developed zebrafish, heart rates increased as the heart developed. Heart rates 
of normally developed zebrafish at 48 hpf and 120 hpf were significantly greater than 
those at 24 hpf when the heart was early developed (Figure 22 A-E). However, Ag NPs 
insignificantly reduced embryo heart rates at 24, 48, and 120 hpf in a dose-dependent 
manner at every stage (Figure 22 A-E). In contrast, cardiac malformed zebrafish found 
after NPs exposure at all concentrations showed insignificant differences in heart rates 
over the examined developmental periods. Their heart rates at 48 hpf and 120 hpf were 
at the same or lower than those at 24 hpf. This suggests that the heart became more 
deformed over time which could lead to lower heart rates, less blood and oxygen supply, 
which possibly attributes to mortality. Ag NPs have previously shown to interfere with 
regular cardiac functions 24,112. Improper blood flow could starve the cells of gases and 
essential nutrients resulting in cell death. It is worth noting that the heart rates of heart 
deformed zebrafish were much lower than normal heart-developed zebrafish (Figure 22 
A-E) but not in a dose-dependent manner. Although the mechanisms are still not well 
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understood, Ag NPs could disrupt heart development contributing to heart deformities and 
then leading to the depressed heart rates.  
In stages I, II, and IV, we observed a huge decrease in the highest treatment group 
(0.50 nM) at 48 hpf.  This decrease shows that at this particular concentration, the effects 
on the cardiac function was significantly influenced by the NPs presence.  This is definitely 
interesting to note, considering that these particular stages are highly significant for 
proper development of the cardiovascular system, and cardiac function, as we can 
observe, is particularly sensitive to any outside toxins.  This can also coordinate with the 
fact that pericardial sac edemas being the most common type of deformity resulting from 
Ag NPs treatment. 
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Figure 22: Quantitative Study of Heart Rates of Treated embryos per stage of 
development.   
Heart rates were measured for each treated embryo at 24 (a), 48 (b), and 120 (c) hpf and 
represented by the lines.  The average number of embryos for 24 (i), 48 (ii), and 120 (iii) 
hpf are plotted in the bar graph.  Stages I – V are shown here (A – E). 
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SUMMARY 
In summary, we examined the biocompatibility and toxicity of single Ag NPs in vivo 
at specific stages of development and the defects associated with treatment at specific 
developmental stages.  Increasing Ag NPs concentration resulted in all stages of 
development resulted in a significant increase in embryonic death, and a correlated 
decrease in survivability of normal and deformed zebrafish.  Many morphological defects 
were observed in the developing embryo, including yolk sac edema, abnormal finfold and 
tail development, head and eye abnormalities, and cardiac malformations at each stage 
of development, corresponding to the stage of treatment.  In general, the number of 
different types of defects and the severity of each varied with the stage of treatment and 
increased with increasing dose of NPs demonstrating the possibility of selectively 
targeting specific embryonic developmental pathways by altering the stage of 
development and dose of NPs for developmental therapeutic studies.  Moreover, it was 
noted that at this particular size of single Ag NPs, cardiac malformation was significant 
no matter the developmental stage.  Pericardial sac edemas were one of the most 
common types of deformity observed throughout the experiment.  In that matter, 
quantitative analysis of cardiac function was found to be significantly influenced with 
increasing Ag NPs concentrations. In particular, we saw a stage-dependent effect on 
cardiac malformation, where stages I, II, and IV were highly influenced by exposure to a 
higher dose of the Ag NPs.  The investigation of biocompatibility of nanomaterials in 
specific stages of development of embryos at single NP level can offer new knowledge 
about the developmental processes and environment, and provide new insights into the 
mechanics of the developing embryo as well as aid in the finding for function 
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MATERIALS AND METHODS 
Reagents and supplies 
Sodium citrate (99%), AgClO4 (99%), NaBH4 (98%), and NaCl were purchased 
from Sigma-Aldrich.  All reagents were used as received.  The nanopure water (18 M 
water, Barnstead) was used to prepare all solutions and rinse glassware. 
Synthesis and characterization of stable and purified Ag NPs 
Ag NPs (41.5 ± 7.6 nm in diameter) were synthesized as we described previously.  
Briefly, sodium citrate (10 mL, 34 mM) was quickly added into a refluxing (100C) AgNO3 
aqueous solution (500 mL, 1.1 mM) under stirring.  The mixture was refluxed and stirred 
for 45 min, as the solution color turned from colorless to straw yellow, then opaque and 
finally muddy yellow.  The heating was stopped and the solution was cooled gradually to 
room temperature under stirring.  The NP solution was filtered using 0.22-µm filters.  All 
chemicals, except those indicated, were purchased from Sigma and used as received.  
The NPs were immediately washed three times with nanopure DI water (18 M, 
Barnstead) using centrifugation (Beckman, JA-14) to remove any residual chemicals 
involved in NP synthesis.  The washed NPs were resuspended in DI water and then egg 
water.  The washed NPs were very stable (non-aggregated) in DI water for months and 
remained stable in egg water (1.0 mM NaCl, 99.95% Sigma, in DI water) throughout the 
duration of the entire experiment (120 h, period of full embryonic development) (Figure 
1).  Concentrations of NPs were calculated, as we described previously.  
Sizes of NPs were characterized using high-resolution transmission electron 
microscopy (HR-TEM) (FEI Tecnai G2 F30 FEG) and dynamic light scattering (DLS) 
(Nicomp 380ZLS particle sizing system).  LSPR spectra and images of single NPs in 
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solution, embryos and embedded in zebrafish tissues were acquired using dark field 
optical microscopy and spectroscopy (DFOMS), which we described previously.  In this 
study, we used a charge coupled device (CCD) camera (Micromax, Roper Scientific) and 
Multispectral Imaging System (Nuance, CRI) was used to acquire LSPR spectra of single 
NPs.   
Stability of NPs in solution and egg water was followed over time for 120 h using 
UV-vis spectroscopy, DLS and DFOMS.  The purified and stable NPs were used for 
probing their diffusion into embryos and their effects on embryonic development. 
Breeding of zebrafish embryos  
Wild-type adult zebrafish (Aquatic Ecosystems) were housed in a stand-alone 
system (Aquatic Habitats), and they were maintained and bred, as we described 
previously.  Briefly, two pairs of mature zebrafish were placed into a clean 10-gallon 
breeding tank.  A light (14 h)–dark (10 h) cycle was used to trigger breed and fertilization 
of embryos.  The embryos at the cleavage stage were collected and transferred into a 
Petri dish containing egg water.  They were well rinsed with egg water to remove any 
possible debris prior to imaging and characterization.  All experiments involving embryos 
and zebrafish were conducted in compliance with IACUC guidelines (protocol # 15-012). 
Treatment and monitoring of zebrafish embryos 
Wild type adult zebrafish (Aquatic Ecosystems) were maintained, bred, and 
collected, as described previously.44, 113  Embryos were collected and transferred into a 
petri dish containing egg water (1.2 mM NaCl), washed twice with egg water to remove 
the surrounding debris, and placed into 48-well plates with each well containing one 
embryo in egg water.  16 embryos were tested per concentration, per stage of 
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development; each experiment was repeated 3 times, totaling 48 embryos analyzed per 
concentration, per stage of development.  Each developmental stage of embryos in the 
wells was directly imaged by bright-field optical microscopy using an inverted Zeiss 
Axiovert microscope equipped with a 4x objective and a digital color camera. 
Study and characterization of transport and biocompatibility of NPs 
To study the dose-dependent effects of NPs on embryonic development, a dilution 
series of washed Ag NP solutions (0, 0.02, 0.05, 0.10, 0.20 and 0.50 nM) were incubated 
acutely with 5 stages of embryos in egg water for 2h.  Each experiment was carried out 
at least 3 times and a total number of 48 embryos were studied for each individual 
concentration to gain representative statistics.  NP concentrations were calculated as 
described previously.44  Embryos in egg water in the absence of NPs and in the presence 
of supernatant were placed in two rows of the 48-well plates as control experiments to 
probe the effects of possible trace chemicals from NP synthesis.  The embryos in the 48-
well plates were incubated at 28.5C, and directly observed at room temperature using 
an inverted Zeiss Axiovert microscope equipped with a digital color camera at 24, 48, 72, 
96, and 120 hpf. 
Quantitative heartbeat study of zebrafish upon Ag NPs concentration 
Both treated and control embryos for stages I - V were analyzed for heart rates.  
Embryos were recorded using the Sony camcorder and Coolsnap Ez (Roper Scientific) 
using 100 frames with a 50 ms interval delay.  The recordings were taken at 24, 48, and 
120 hpf.  The movies were then converted and analyzed for manual counting of the hearts 
contractions.  The heartbeat per minute was then compared graphically to both the normal 
and abnormal developed fish at each concentration. 
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Data analysis and statistics 
A minimum of 100 Ag NPs was imaged and characterized for each measurement 
of their sizes and stability in egg water using HRTEM and DFOMS.  A minimum of 300 
NPs in total was studied for each sample via three repeated measurements.  For the 
study of dose-dependent effects and qualitative heart rate analysis of NPs on embryonic 
development, a total number of 48 embryos were studied for each NP concentration and 
each control experiment over 120 hpf with a minimum of 12 embryos studied in each 
measurement.  We presented averaged the number of normally developed, dead and 
deformed zebrafish vs. Ag+ concentration with standard deviations.  We used 
conventional statistical analysis methods (t-test, ANOVA, Tukey’s, SPSS Statistics with 
P = 0.05) to determine the significance of the different observations between all 
concentrations for development, hatching, heartrate and uptake results.  A Pairwise T-
test comparison was performed of Deformities Histogram. 
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CHAPTER V 
STUDY OF EFFECTS OF SILVER NANOPARTICLES ON EARLY NEUROLOGICAL 
DEVELOPMENT OF ZEBRAFISH EMBRYOS 
INTRODUCTION 
Our lab has previously demonstrated that stable purified silver nanoparticles can 
induce unique and rare abnormalities in developing embryos. 114-118 The abnormal 
phenotypes in development included cardiac malformations, abnormal tail and spinal cord 
formation, and head and severe eye abnormalities.  We wanted to understand more about 
how and why these unique phenotypes occur from exposure to silver nanoparticles, 
understanding the molecular mechanisms that are involved and identify primary biological 
biomarkers that are highly influenced during embryogenesis from this induced 
nanotoxicity. 
The development of the brain and all of its mysteries is still an area that needs to 
be explored.  Neurological development is a well-regulated and regionalized operation 
that is highly complex during embryogenesis. 119  Studies show that the formation of the 
embryonic brain requires interaction from many essential biomarkers and inductive 
interactions between different regions of the developing embryo.  In recent genetic 
studies, some of these key biomarkers that play important roles within the developmental 
process have been recognized, but exact mechanisms are still being explored.  Some of 
these biomarkers include the signaling molecules like noggin and follistatin, and the 
regulating transcription factors otx, emx, pax, and engrailed genes.  Although the genetic 
assay approach allows for detailed genetic information to be discovered, this approach 
still limits the understanding of mechanisms and the dynamics of these biomarkers in real 
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time.  They limit the view of understanding in cases where the molecular process is trying 
to be correlated.  We aim to approach this with a different strategy that allows us to study, 
in real time, how these key biomarkers are influenced during development by 
nanotoxicity.   
To approach this, we chose to identify a key neurological protein biomarker that 
has shown to have fundamental responsibility during neurological development.  Pax2a 
gene is a prominent protein that plays important roles in central and peripheral nervous 
system development.   
Paired box gene 2a (pax2a) is highly expressed during the segmentation stage of 
development, largely involved in the formation of the midbrain-hindbrain boundary.  This 
region of the developing embryonic brain is essential to pattern formation and 
organization of neural networks in both adjacent midbrain and hindbrain zones.  Pax2a is 
also uniquely expressed during eye and ear morphogenesis and has been shown to be 
involved in multicellular organism development, like kidney, locus cerebellum formation, 
otic placode formation, peripheral and central nervous system development, and 
pronephros development. 120, 121  Transgenic zebrafish models expressing the pax2a 
gene have been used to study the developmental migration of neuronal cells as well as 
targeted for toxicological studies.122-127 This biomarker is important in this study because 
mutations in the pax2a gene results in abnormal phenotypes in developing embryos that 
showed similarities to those induced in our nanotoxicity studies.120-122, 128 
Nanoparticles (NPs) are ideal for biomedical research in developmental biology 
because of their unique capability in probing the nanoscale environments of living 
organisms, enabling the study of a developing organism at different developmental 
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stages.72, 83-86  Their unique optical properties makes imaging in vivo more convenient, 
allowing the transport and diffusion of the NP to be monitored and offers new information 
on the developing fluid mechanics of the embryonic organism.  NP probes can be used 
in a variety of applications for new insight into developmental processes, such as 
development screening tools in developmental biology to investigate the embryonic 
internal environment, to potentially control and regulate certain processes in 
development, and to target specific system regulators for biomedical biological uses.  
Nanomaterials could possibly demonstrate developmental stage-dependent regulation of 
deformity type induced, suggesting that the nanomaterials, at higher concentration, may 
interact with target developmental pathways of interest.  In this study, we used our 
previously described nanomaterials,44 Ag NPs, and an effective embryo developmental 
model system, zebrafish embryos, and focused on  biocompatibility targeting important 
transgenic developmental in vivo models for analysis and independent NP entry into each 
embryonic stage, hoping to identify possible developmental stage applications and the 
ability for NPs to enter the developing embryo independent of the time of development. 
Ag NP probes have unique optical properties over many fluorescent imaging 
approaches because they have localized surface plasmon resonance (LSPR), enabling 
characterization of their size and shape, and they offer high quantum yield (QY) of 
Rayleigh scattering making them bright and easy to see using dark-field optical 
microscopy and spectroscopy (DFOMS).60, 95-97  Ag NPs can be used as a probe for real-
time study over an unlimited period of time because they do not experience 
photodecomposition as fluorescent beads can.  In addition, the LSPR spectra, or color of 
the Ag NPs, can be used to show size-dependence.60, 95, 96  Using the LSPR spectra of 
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the multicolor Ag nanoparticles it is possible to be able to directly characterize the 
diffusion of the same color nanoparticle at the nanometer scale in real-time, in different 
biological environments based on using the same sized Ag NPs.93, 98, 99 
Zebrafish (Danio rerio) have been extensively employed as a well-studied 
vertebrate model for embryological development because of its small size, its short 
breeding cycle, and the wealth of information available for manipulation.63, 70, 100-102  Their 
transparency throughout development allows observation of all internal organ 
development from outside the chorion without disturbing the living embryo.  Zebrafish are 
time efficient for care and maintenance and they effortlessly spawn in large numbers from 
week to week producing macroscopic fertilized eggs, which are ideal for observing 
different developmental stages.  The embryonic development is so rapid that the first 
stages of development are completed in the first 24 hours post fertilization (hpf) and the 
normal embryo will hatch and swim by 72 hpf.  The majority of developmental mutations 
identified in zebrafish have close counterparts in other vertebrates, suggesting that this 
system can be effectively used as a model for understanding the developmental 
processes of higher organisms, including humans.66, 103  Therefore, zebrafish embryos 
offer a unique opportunity to investigate developmental processes upon treatment with 
NPs to investigate stage dependence NP effects on embryonic development. 
It is important to explore the biocompatibility of Ag NPs during embryonic 
development to access the ability of Ag NPs to be used for in vivo imaging at any 
embryonic stage of development as well as probes in real-time to explore the changing 
embryonic environment during development, including neurological changes and 
understanding mechanism in brain development. 
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This study aimed to understand in real time how a key neurological developmental 
biomarker is influenced in the presence of Ag NPs, thus allowing us to explore their 
mechanisms and roles during embryogenesis.  We designed an ultrasensitive in vivo 
bioanalytical imaging tool to study molecular changes at the single cell resolution of cells 
expressing Pax2a protein biomarkers.  Using transgenic zebrafish models, we were able 
to determine the effects of Ag NPs and understand how nanotoxicity can influence the 
molecular mechanism of these protein biomarkers in expressing cells at various stages 
of embryogenesis.  
To that end, we selected a vital protein biomarkers that play important roles in 
neurological development, used transgenic embryos that express the protein biomarkers 
fused with fluorescence proteins as model organisms, and studied the effects of NPs on 
their functions using fluorescence microscopy and plasmonic spectroscopy.  
RESULTS AND DISCUSSION 
Synthesis and characterization of Ag nanoparticles (NPs)  
Ag NPs were synthesized, purified and characterized, as described in Methods.  
Notably, highly purified Ag NPs were produced by thoroughly washing Ag NPs with 
deionized (DI) water to remove potential residual chemicals involved in NP synthesis via 
centrifugation.  A representative optical image of Ag NPs in Figure 23 C illustrates that 
the majority of NPs appear to be blueish green to green, with a few reds.  These results 
suggest that Ag NPs are uniform in size and shape based on their color (LSPR).  The 
representative LSPR spectra of single blue, green and red Ag NPs with peak wavelengths 
(λmax) at 468 nm (blue) (FWHM = 38 nm), 554 nm (green) (FWHM = 47 nm), and 659 nm 
(red) (FWHM = 47) nm, respectively (Figure 23).  Thus, the color of Ag NPs can be used 
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as size index to directly distinguish and determine the size of NPs using DFOMS, even 
though the size of NPs cannot be directly measured due to the optical diffraction limit. 
The NPs were then suspended in egg water (1.0 mM NaCl, embryonic medium) for the 
study of their stability and their effects on embryonic development. We characterized the 
stability, size and optical properties of the purified Ag NPs in egg water embryo media 
(1.0 mM NaCl) for 120 h using UV-vis absorption spectroscopy, dark field optical 
microscopy and spectroscopy (DFOMS) and high-resolution transmission electron 
microscopy (HRTEM). The size was with an average diameter of 41.5 ± 7.6 nm (Figure 
23). We found that the number of NPs remained relatively unchanged when incubated in 
egg water for 120 h.  The absorbance spectra of freshly prepared and purified Ag NPs 
before and after the incubation time with egg water demonstrated a peak wavelength 
(λmax) at 401 nm (FWHM = 52 nm) and only showed a slight decrease in absorbance for 
120 hours (Figure 23).  The unchanged number of NPs and stable absorbance spectra 
indicates that the Ag NPs are very stable in egg water media and remain non-aggregated 
throughout the entire experiment. 
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Figure 23: Characterization of sizes, shapes, and plasmonic optical properties of 
single Ag NPs.   
(A) Dark-field optical image of single NPs shows that a majority of NPs are plasmonic 
green with some blue-green and red. (B) LSPR spectra of representative single NPs (C) 
HRTEM image shows the spherical shape of single NPs. (D) Histogram of size distribution 
of single NPs determined by HRTEM shows average diameters of 41.5 ± 7.6 nm.  
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Figure 24: Characterization of stability of Ag NPs in egg water (CNPs = 0.5 nM) for 
120 h. 
(A) UV-Vis absorption spectra of the NPs dispersed in egg water at 28.5 °C for (a) 0 and 
(b) 120 h show that its peak absorbance of 401 nm shows only a slight decrease after 
incubation r for 120 h. (B) The average of total number of NPs from triplicate runs at (a) 
2 h, (b) 48 h, and (c) 120 h in both egg water and deionized nanopure water.  The average 
total number of NPs is 501, 520, and 492, respectively in egg water, and 475, 474, and 
510 respectively in nanopure water. The 10 images are acquired at each given time point 
using DFOMS. 
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Early-development transgenic embryos as ultrasensitive in vivo assays   
Optical images in Figure 25 A shows normal developmental stages of zebrafish 
embryos, which includes cleavage (0.75-2.25 hours-post-fertilization, hpf), early 
segmentation (12 hpf), late segmentation (24 hpf), hatching stages (48 hpf and 72 hpf 
and a fully developed zebrafish (120 hpf).  All embryonic developmental stages of 
zebrafish are well defined. 40, 66, 68, 103  The earlier developmental stage, such as cleavage 
stage, is likely more prone and sensitive to the effects of external substances (e.g., drugs, 
NPs) than later stages.  Notably, during the cleavage-stage embryos undergo drastic 
changes to lay down the foundation for developing different organs. Their related and 
important developmental mechanisms remain not yet fully understood.59, 100, 101  Thus, we 
select cleavage-stage embryos for the study of biocompatibility and toxicity of NPs, 
aiming to develop ultrasensitive in vivo assays for effectively screening of NPs and to 
rationally design biocompatible NP probes for in vivo imaging.    
Study of dose-dependent biocompatibility and toxicity of NPs and control 
experiments 
We studied dose-dependent toxic effects of NPs on embryonic development by 
incubating cleavage-stage embryos with various concentrations (0- 5.00 pM) of Ag NPs 
suspended in egg waters for 120 h.  Representative embryonic developmental stages 
were imaged and assayed over time until the embryos were fully developed.  The number 
of embryos that developed to normal zebrafish (Figure 25 A), became dead (Figure 25 
B), and deformed zebrafish (Figure 26 B) were recorded.    
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Figure 25: Study of dose-dependent effects of Ag NPs on embryonic development 
using embryos as ultrasensitive in vivo assays.  
(A) Optical images of normally developing embryos at (a) cleavage-stage (0.75-2.25 hpf); 
(b) late gastrula stage (10 hpf); (c) late segmentation stage (24 hpf); (d) hatching stage 
(48 hpf); (e) 72 hpf hatched embryo; (f) fully developed larvae (120 hpf).  (B) Dead 
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embryo.  (C) Histograms of distributions of embryos that developed to normal and 
deformed zebrafish or became dead versus NP concentration.  (D) Control experiments: 
histograms of the distributions of embryos that developed to normal zebrafish or became 
dead either in egg water alone or versus concentration of supernatant, which was 
collected from the last washing of NPs with DI water. A total of 48 embryos were studied 
for each NP concentration and control in  
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Figure 26:  Dependence of types of deformed zebrafish on NP concentration.   
(A) Optical image of a normally developed Zebrafish Larvae at 120 hpf.  (B) Optical 
images of deformed zebrafish show: (a-b) head and eye abnormities; (c-d) pericardial sac 
and yolk sac edema; (e) tail/spinal cord flexure; and (f) finfold abnormalities.  (B) 
Histograms of distributions of embryos that developed to deformed zebrafish with six 
distinctive types of deformities at NP concentration of 0.5, 1.0, 2.0 and 5.0 pM.  Scale bar 
is 500 µm for all images in (A) and (B).  
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Similar to our chronic study using similar sizes on wild type zebrafish embryos, the 
effects of 43 nm Ag NPs on pax2a transgenic embryos resulted in dose-dependent 
toxicity, as well as phenotypical dependent effect upon exposure to Ag NPs.  This, again, 
shows that the larger NPs are more toxic than smaller NPs. 
Expression of pax2a:GFP in Ag NPs treated embryos 
 Treated transgenic embryos that were positive for the GFP protein was 
imaged for their protein expression at key developmental time points during brain 
development, shown in Figure 27.  In the normally developed zebrafish, we observed the 
expression of pax2a:GFP to decrease during brain development.  This correlates with the 
function of the pax2a gene.  In fact, the analysis of the pax2.1 gene in zebrafish shows 
embryonic expression pattern and requirement is regulated after brain development. 120, 
126  The pax2a:GFP expression is most significant during early brain development, during 
the midbrain-hindbrain boundary constriction. 129  Figure 28 shows examples of the GFP 
expression during 15 hpf (A), 24 hpf (B), and 48 hpf (C).   Figure 29 shows the 
intensity of the GFP embryonic expression at 24 hpf.  Here, we observed that in 
expression intensity decreased slightly as the Ag NPs concentration increase in normally 
developed zebrafish.  However, we did not observe this decrease to be significantly 
different from our control embryos.  These results may show that the pax2a gene is not 
greatly affected by exposure of Ag NPs, however, other upregulated genes might still be 
hugely affected, considering the phenotypical morphologies we see from treated 
embryos.  This in vivo assay may be used to explore those genes in more details 
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Figure 27: Representative images of Expression of Tg(pax2a:GFP) in developing 
embryos exposed to Ag NPs. 
Fluorescence imaging of the expression patterns of the zebrafish embryos captured at 
(A) 15 hpf, (B) 24 hpf, (C) 48 hpf, (D) 72 hpf, (E) 96 hpf, and (F) 120 hpf for all NPs treated 
concentrations of (a) 0.00 pM, (b) 0.50 pM, (c) 1.00 pM, (d) 2.00 pM, and (e) 5.00 pM.  
Expression is shown in the midbrain, hindbrain regions, and along the spinal cord of the 
growing zebrafish.  Expression does decrease over time.  Imaging was captured using a 
Coolsnap HQ (Photometrics) CCD using 4x objective and GFP (455 ex /505 dclp/525 em) 
custom cube. 
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Figure 28: Development of Tg(pax2a:GFP) embryos at 1 key developmental stages 
of brain development. 
Optical (a) and Fluorescence (f) imaging of embryos at different developmental time 
points; (A) 15 hpf, (B) 24 hpf, and (C) 48 hpf.  Expression patterns are found along the 
midbrain and hindbrain areas during brain development.  The midbrain-hindbrain 
segmentation can clearly be observed from the expression of GFP.  Imaging was 
captured using a Coolsnap HQ (Photometrics) CCD using 10x objective. 
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Figure 29: Expression of pax2a:GFP protein in zebrafish embryos at 24 hpf. 
(A) Representative 10x images of 24 hpf embryos.  (a) Optical image of a 24 hpf 0.00 pM 
control embryo (b) Fluorescence image of a 24 hpf 0.00 pM control embryo (c) Optical 
image of a 24 hpf 5.00 pM control embryo (f) Fluorescence image of a 24 hpf 5.00 pM 
control embryo. Imaging of the expression patterns was captured in the hindbrain area 
beside the optic placode. Imaging was captured using a Coolsnap HQ (Photometrics) 
CCD using 10x objective. (B) Histogram of  GFP intensity plotted in over different 
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treatments at 24 hpf in treated embryos;  (a) Individual normally developed 0.00 pM 
embryos fluorescent intensity, (b) Individual normally developed 0.50 pM embryos 
fluorescent intensity, (c) Individual normally developed 1.00 pM embryos fluorescent 
intensity, (d) Individual normally developed 2.00 pM embryos fluorescent intensity, (e) 
Individual abnormally developed 2.00 pM embryos fluorescent intensity, (f) Individual 
normally developed 5.00 pM embryos fluorescent intensity, (g) Individual abnormally 
developed 5.00 pM embryos fluorescent intensity.  Scale bar for images in (A) was 350 
µm. 
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Quantitative heartbeat study of zebrafish upon Ag NPs concentrations. 
With many of the Ag NPs treated zebrafish resulting in pericardial sac edemas, 
along with other cardiac malfunctions, we further monitored the effects of Ag NPs on heart 
function of developing zebrafish.  We compared those treated with Ag NPs with control 
zebrafish at three major developmental time points: 24 hpf (early heart formation period); 
48 hpf (embryo hatching period); and 120 hpf (full development period). We found that 
the number of embryos with normal developed heart decreased as the Ag NPs 
concentration increased since some embryos exposed to Ag NPs became either dead or 
deformed. In normally developed zebrafish, heart rates increased as the heart developed. 
Heart rates of normally developed zebrafish at 48 hpf and 120 hpf were significantly 
greater than those at 24 hpf when the heart was in early cardiogenesis development 
(Figure 30 A). However, Ag NPs significantly reduced embryo heart rates at 24, 48, and 
120 hpf in a dose-dependent manner (Figure 30 A). In contrast, deformed zebrafish found 
after Ag NPs exposure at 1.00 – 5.00 pM concentrations showed a significant difference 
in heart rates over developmental periods. Their heart rates at 48 hpf and 120 hpf were 
at the similar to those at 24 hpf (Figure 30 B) in normal embryos. Ag NPs have previously 
shown to interfere with regular cardiac functions. 24,112  Significantly enough, we noted 
that the heart rates of heart deformed zebrafish were much lower than normal heart-
developed zebrafish (Figure 30 B) but not in a dose-dependent manner.  
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Figure 30: Quantitative analysis of heartbeat of normally developed and heart 
deformed zebrafish.  
Plots of heartbeat per minute of normally developed zebrafish (A) and of deformed 
zebrafish (B) at (a) 24 hpf which is an early stage of heart development, (b) 48 hpf which 
is a hatching stage, and (c) 120 hpf when zebrafish fully developed versus Ag NPs 
concentrations. Histogram (secondary axis) presents the total numbers of zebrafish from 
three replicates used for heartbeat analysis at 24 hpf (i), 48 hpf (ii), and 120 hpf (iii). 
Comparison of heartbeats between normal and deformed zebrafish (C) demonstrates that 
heartbeat of the normal zebrafish at (a) 24 hpf, (b) 48 hpf, and (c) 120 hpf are higher than 
deformed zebrafish (a’) 48 hpf and (b’) 120 hpf.  Note that there were no deformed 
zebrafish present at 24 hpf. 
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Dose-dependent exposure to Ag NPs on optical development  
Because head and eye abnormalities are readily recorded from exposure of single 
Ag NPs from different sizes, an assay designed to analyze the craniofacial development 
in zebrafish was explored.  Analysis of the fully developed zebrafish optic area was 
observed at 120 hpf.  Eye measurements were plotted for all normally and abnormally 
developed zebrafish.  Figure 31 A shows the optical examples of how these 
measurements were taken, as further described in the Methods section.  We observed 
that as the concentration of the Ag NPs increased, the average size of the eye area of 
both normal and deformed zebrafish larvae decreased, where 5.00 pM showed the 
smallest size. Notably, those zebrafish that were deformed showed a significantly smaller 
size of the eye area.  Microphthalmia, the condition of reduced eye sizes in developing 
embryos, can occur as a consequence of several developmental mechanism including 
increased cell death or reduced cell proliferation in the developing eye. 130  This condition 
in zebrafish has also affected behavioral response to light stimulation during behavioral 
studies. 131  In fact, microphthalmia is associated with contralateral brains structural 
abnormities, resulting in unresponsive optical development.   
Our results show that Ag NPs exposure highly influences the development of the 
eye and other craniofacial areas, which can have permanent effects in the adult zebrafish.  
Further research will need to be applied to investigate the mechanism that is responsible 
for this developmental delay. 
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Figure 31: Zebrafish embryos exposed to Ag NPs result in microphthalmia after 120 
h incubation.   
Analysis of eye measurements of Zebrafish at 120 hpf.  The yellow dashed outlines 
highlights measured areas taken for each embryo.  (A) Representative 10x images of 120 
hpf zebrafish.  (a) 0.00 pM normally developed embryo (b) 5.00 pM abnormally developed 
embryo. Imaging was captured using a Coolsnap HQ (Photometrics) CCD using 10x 
objective. (B) Histogram of  GFP intensity plotted in over different treatments at 24 hpf in 
treated embryos;  (a) Individual normally developed 0.00 pM embryos fluorescent 
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intensity, (b) Individual normally developed 0.50 pM embryos fluorescent intensity, (c) 
Individual normally developed 1.00 pM embryos fluorescent intensity, (d) Individual 
normally developed 2.00 pM embryos fluorescent intensity, (e) Individual abnormally 
developed 2.00 pM embryos fluorescent intensity, (f) Individual normally developed 5.00 
pM embryos fluorescent intensity, (g) Individual abnormally developed 5.00 pM embryos 
fluorescent intensity.  Scale bar for images in (A) was 350 µm. 
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Quantitative study of accumulation of Ag NPs in developing zebrafish embryos  
Our previous studies have shown how different sizes of Ag NPs can diffuse into 
different locations of a developing zebrafish after chronic and acute exposure.  Here, we 
quantitatively plotted the uptake of Ag NPs during chronic exposure to Ag NPs.  Figure 
32 shows the amount of Ag NPs in pmoles that was removed by normal, deformed, and 
dead embryos.  As noted, we observed a dose-dependent trend of uptake of Ag NPs in 
treated embryos as the concentration of the NPs increased.  In those embryos that were 
deformed or dead during treatment, the amount of Ag NPs was significantly higher than 
those that developed normally.  These normally developed embryos also were more 
apparent in normal embryo behavior like hatching from the embryos protective barrier, 
the chorion, and swimming reflexes.  We observed those embryos who were developed 
abnormally had delayed hatched response, hatching at time points later than normal 
range of 48 – 72 hpf.  It is also notable that those embryos who did not survive during 
treatment still resulted in higher NPs uptake.  This increased uptake significantly 
corresponds to the mortality rate displayed in Figure 25.   
This might be because those normally developed embryos were more resistant to 
the diffusion of the NPs.  These results are similar to uptake studies of commercial metal 
and metal oxide nanoparticles when acutely exposed at much higher rates. 132  This 
proves the need to observe and study the uptake of nanomaterials during toxicity studies, 
and to further study the molecular mechanisms that could potentially be responsible for 
this uptake.   
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Figure 32: Quantitative study of accumulation of Ag NPs in normally developed and 
deformed zebrafish after treatment.  
Plot of the amount of Ag NPs in embryos of single larvae (A) and of average accumulation 
for each treatment group (B) after 120 hpf.  Solution from each individual well was 
collected at the start and end of treatment and the absorption, measured using UV-Vis 
spectroscopy, was used to calculate the number of nanoparticles that accumulated in the 
embryos during treatment.  Plot shows the results for the normal, deformed, and dead 
zebrafish.  
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SUMMARY 
Embryonic neurological development composes of many different components 
that all work in unison to develop a functional pathway of neurological function.  This study 
objectively aimed to solidify a more cohesive understanding of how the pax2a functional 
pathway operates, while at the same time explores how nanotoxicity can inhibit or 
influence the behavior of these pathways.  We found that exposure of Ag NPs (41.5 ± 7.6 
nm in diameter) have a dose-dependent effect on Tg(pax2a:GFP) embryos during 
embryogenesis.  Sublethal concentrations of the Ag NPs also showed a phenotypical 
dependent morphological effect during development.  However, we did not observe a 
significant decrease in expression of GFP when exposed to Ag NPs.  We observed that 
a higher dose of the Ag NPs leads to severe deformities.  We also demonstrated the 
effects of Ag NPs on cardiac response during exposure.  We observed that Ag NPs can 
decrease the heart rate of both normal and deformed zebrafish.  This study also 
demonstrated dose-dependent effects of Ag NPs on eye development, where higher 
concentrations of the Ag NP lead to microphthalmia.  We also designed an in vivo assay 
to study the uptake of Ag NPs in developing embryos.  Here, we observed a significant 
difference in uptake of those embryos that developed abnormally or who did not survive 
during treatment.   
This study emphasized different in vivo assays that can be explored to gain more 
knowledge on neurological development in zebrafish, which can lead to better design or 
more biocompatible biosensors to explore therapeutic and molecular assays of 
embryogenesis and neurological diseases. 
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METHODS 
Reagents and supplies 
Sodium citrate (99%), AgClO4 (99%), NaBH4 (98%), and NaCl were purchased 
from Sigma-Aldrich.  All reagents were used as received.  The nanopure water (18 M 
water, Barnstead) was used to prepare all solutions and rinse glassware. 
Synthesis and characterization of Ag nanoparticles (NPs)  
We used our previous developed sphere-shaped silver-based nanoparticles that 
were washed and purified to remove any chemicals that remained from the synthesis to 
study their interactions and biocompatibility to determine Ag NPs role in developmental 
processes, including concentration-dependent morphological responses, for the potential 
of use as developmental intermediates for biomedical applications.44  We characterized 
the stability, size and optical properties of the purified Ag NPs in egg water embryo media 
(1.2 mM NaCl) for 120 h using UV-vis absorption spectroscopy, dark field optical 
microscopy and spectroscopy (DFOMS) and high resolution transmission electron 
microscopy (HRTEM). The size was with an average diameter of 41.5 ± 7.6 nm (Figure 
21 ).  A representative optical image of Ag NPs in Figure 21C illustrates that the majority 
of NPs appear to be blueish green to green, with a few reds.  These results suggest that 
Ag NPs are uniform in size and shape based on their color (LSPR).  The representative 
LSPR spectra of single blue, green and red Ag NPs with peak wavelengths (λmax) at 468 
nm (blue) (FWHM = 38 nm), 554 nm (green) (FWHM = 47 nm), and 659 nm (red) (FWHM 
= 47) nm, respectively (Figure 21).  Thus, the color of Ag NPs can be used as size index 
to directly distinguish and determine the size of NPs using DFOMS, even though the size 
of NPs cannot be directly measured due to the optical diffraction limit. We found that the 
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number of NPs remained relatively unchanged when incubated in egg water for 120 h.  
The absorbance spectra of freshly prepared and purified Ag NPs before and after the 
incubation time with egg water demonstrated a peak wavelength (λmax) at 401 nm (FWHM 
= 52 nm) and only showed a slight decrease in absorbance for 120 hours (Figure 22).  
The unchanged number of NPs and stable absorbance spectra indicates that the Ag NPs 
are very stable in egg water media and remain non-aggregated throughout the entire 
experiment. 
Synthesis and characterization of stable and purified Ag NPs 
Ag NPs (41.5 ± 7.6 nm in diameter) were synthesized as we described previously.  
Briefly, sodium citrate (10 mL, 34 mM) was quickly added into a refluxing (100C) AgNO3 
aqueous solution (500 mL, 1.1 mM) under stirring.  The mixture was refluxed and stirred 
for 45 min, as the solution color turned from colorless to straw yellow, then opaque and 
finally muddy yellow.  The heating was stopped and the solution was cooled gradually to 
room temperature under stirring.  The NP solution was filtered using 0.22-µm filters.  All 
chemicals, except those indicated, were purchased from Sigma and used as received.  
The NPs were immediately washed three times with nanopure DI water (18 M, 
Barnstead) using centrifugation (Beckman, JA-14) to remove any residual chemicals 
involved in NP synthesis.  The washed NPs were resuspended in DI water and then egg 
water.  The washed NPs were very stable (non-aggregated) in DI water for months and 
remained stable in egg water (1.0 mM NaCl, 99.95% Sigma, in DI water) throughout the 
duration of the entire experiment (120 h, period of complete embryonic development) 
(Figure 22).  Concentrations of NPs were calculated, as we described previously.  
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Sizes of NPs were characterized using high-resolution transmission electron 
microscopy (HR-TEM) (JEOL, JEM-2100F) and dynamic light scattering (DLS) (Nicomp 
380ZLS particle sizing system).  In this study, the DFOMS is equipped with a dark-field 
optical microscope with a dark-field condenser (oil 1.43–1.20, Nikon) and a 100× objective 
(Nikon Plan fluor 100× oil, iris, SL. N.A. 0.5–1.3, W.D. 0.20 mm), a CCD camera 
(Micromax, Roper Scientific) and a Multispectral Imaging System (Nuance, CRI) was 
used to acquire LSPR spectra of single NPs. Stability of NPs in solution and egg water 
was followed over time for 120 h using UV-vis spectroscopy, DLS and DFOMS.   
Breeding of zebrafish embryos  
Wild-type adult zebrafish (Aquatic Ecosystems) and Tg(pax2a:GFP) adult 
zebrafish were housed in a stand-alone system (Aquatic Habitats), and they were 
maintained and cross-bred, as described previously.44, 113  Briefly, two pairs of mature 
female transgenic zebrafish and with one wild type male were placed into a clean 10-
gallon breeding tank.  A light (14 h)–dark (10 h) cycle was used to trigger breed and 
fertilization of embryos.  The embryos at the cleavage stage were collected and 
transferred into a Petri dish containing egg water.  They were well rinsed with egg water 
to remove any possible debris prior to imaging and characterization.  All experiments 
involving embryos and zebrafish were conducted in compliance with IACUC guidelines 
(protocol # 15-012). 
Treatment and monitoring of zebrafish embryos 
Embryos were collected and transferred into a petri dish containing egg water (1.2 
mM NaCl), washed twice with egg water to remove the surrounding debris, and placed 
into 48-well plates with each well containing one embryo in egg water.  16 embryos were 
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tested per concentration, per stage of development; each experiment was repeated 3 
times, totaling 48 embryos analyzed per concentration, per stage of development.  Each 
developmental stage of embryos in the wells was directly imaged by bright-field optical 
microscopy using an inverted Zeiss Axiovert microscope equipped with a 4x objective and 
a digital color camera. 
Study and characterization of biocompatibility and toxicity of NPs  
The cleavage-stage embryos in egg water were incubated with a dilution series of 
NPs (0, 0.50, 1.00, 2.00 and 5.00 pM).  Each experiment was carried out at least 3 times 
and the total number of embryos, 48, were studied for each individual concentration to 
gain representative statistics.  NP concentrations were calculated as described 
previously.44  Embryos in egg water in the absence of NPs and in the presence of 
supernatant were placed in two rows of the 48-well plates as control experiments to probe 
the effects of possible trace chemicals from NP synthesis.  The embryos in the 48-well 
plates were incubated at 28.5C, and directly observed at room temperature using an 
inverted Zeiss Axiovert microscope equipped with a digital color camera at 24, 48, 72, 96, 
and 120 hpf.  Using fluorescent microscopy equipped with filters specific for GFP (455 ex 
/505 dclp/525 em), expression of pax2a:GFP will be captured using CCD.  Positive 
embryos were imaged in real time at key developmental time points that are important to 
Brain development (i.e. around the somites and otic placode regions at 17 hpf, and areas 
designated for midbrain and hindbrain at 21 hpf) using 10x objective and at each 
additional imaged time point using 4x objective.  Embryos were monitored in real time to 
note any significant changes in the expression of the protein biomarkers in the presence 
of Ag NPs as well as any abnormal developmental phenotypes that occur from exposure. 
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Quantitative heartbeat study of zebrafish upon Ag NPs concentrations 
Both treated and control embryos f were analyzed for heart rates.  Embryos were 
recorded using the Sony camcorder and Coolsnap Ez (Roper Scientific) using 100 frames 
with a 50 ms interval delay.  The recordings were taken at 24, 48, and 120 hpf.  The 
movies were then converted and analyzed for manual counting of the hearts contractions.  
The heartbeat per minute was then compared graphically to both the normal and 
abnormal developed fish at each concentration. 
Dose-dependent accumulation of Ag NPs in developing zebrafish embryos 
Treatment solution was sampled out at the start of treatment and at the end of 
treatment.  The solution was then analyzed using UV-Vis Spectroscopy and spectral 
analysis was used to calculate the amount (pmole) of Ag NPs remaining in the solution.  
This was then used to calculate the uptake amount (pmole) of Ag NPs that was delivered 
to the embryo. 
Data analysis and statistics 
A minimum of 100 Ag NPs was imaged and characterized for each measurement 
of their sizes and stability in egg water using HRTEM and DFOMS. For the study of dose-
dependent effects and qualitative heart rate analysis of NPs on embryonic development, 
a total number of 48 embryos were studied for each NP concentration and each control 
experiment over 120 hpf with a minimum of 12 embryos studied in each measurement.  
Expression data analysis was taken for all positive embryos from each experiment, 
totaling a number of 24 embryos per concentration for expression analysis. 
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CHAPTER VI 
CONCLUSION 
In conclusion, as described in chapter II, we utilized zebrafish embryos as our in 
vivo model organism to study the toxicity of Ag+ ions.  By statistically comparing the 
distributions of normal, deformed, and dead embryos upon their exposure to various 
concentrations of Ag+ ion, we found that the Ag+ ion caused deformities and death of the 
developing embryos in a concentration-dependent manner, where the critical 
concentration of the Ag+ ion was 0.20 µM.  Exposure of Ag+ ions led to specific types of 
defects in development. However, it is far less drastic than the developing embryos were 
exposed to Ag NPs.  Thus, we can conclude that toxicity of Ag NPs is not due to the 
release of its ions, but rather their own unique physicochemical properties.  To this notion, 
further investigation into mechanisms of toxicity of Ag NPs is needed to truly understand 
them.  We found that the Ag+ ion highly affected embryonic development of cardiac 
formation and function.  We found that heart rate highly depends upon Ag+ concentration.  
Likewise, we found a large decrease in embryonic heart-rate of those zebrafish that 
developed abnormally, which were significantly lower than the controls at every 
development stage.  We also found that hatching was significantly delayed for embryos 
treated at higher concentrations of the Ag+. 
In chapter III, we utilized the developing embryos as in vivo model organisms used 
in chapter I, and the same dilution series of Ag+ concentrations to study the stage-
dependent biocompatibility and toxicity effects of Ag+. Specific developmental stages 
during embryogenesis were selected.  We observed that the Ag+ resulted in 
concentration-dependent toxicity similar to chapter I in all developmental stages.  Our 
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results describe a range of developmental defects and absolute death following exposure 
of developing zebrafish embryos to micromolar concentrations of Ag+ at particular 
embryonic development stages.  We also observed cardiac malfunction in all treated 
stages, where the Ag+ resulted in a significant decrease in heart rate with increasing 
concentration.  We did also observe a significant decreased in deformed embryos.  
Similar to results described in chapter I, when comparing the sensitivity of these specific 
developmental stages to exposure of the Ag+ to those same specific developmental 
stages exposed to our Ag NPs, we found the Ag+ did not cause toxicity as severely as 
NPs.  This finding further suggests that the toxicity of Ag NPs are not caused by its ions, 
but its own unique properties.  This study offers new insight into the need to further study 
the effects of nanomaterials on developmental biology.  
In chapters IV and V, the stability of purified Ag NPs (42 nm) in egg media was 
comprehensively characterized before using them to study the biocompatibility and 
toxicity of Ag NPs on embryonic development.  We found that the NPs remained stable 
in egg water up to 120 h, the duration of entire embryonic development. 
 In chapter IV, we examined the effects of Ag NPs upon the development of specific 
stages of development and the defects associated with treatment at those specific 
developmental stages.  The design of this study was used in this dissertation to compare 
stage-specific toxicities of Ag+ ion from chapter II to the toxicity of Ag NPs.  In this study, 
we observed that increasing NPs concentration at all stages of development resulted in 
a significant increase in embryonic death and a correlated decrease in survivability of 
normal and deformed zebrafish.  Many morphological defects were observed in the 
developing embryo, including yolk sac edema, abnormal finfold and tail development, 
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head and eye abnormalities, and cardiac malformations at each stage of development.  
In general, the number of different types of defects and the severity of each varied with 
the stage of treatment and increased with increasing dose of NPs demonstrating the 
possibility of selectively targeting specific embryonic developmental pathways by altering 
the stage of development and dose of NPs for developmental medicinal studies.  
Moreover, it was noted that at this particular size of single Ag NPs, cardiac malformation 
was significant despite exposure at different developmental time points.  Pericardial sac 
edemas were one of the most common types of deformity observed throughout all stages.  
In that matter, quantitative analysis of cardiac function was found to be significantly 
influenced with increasing Ag NPs concentrations. In particular, we saw a stage-
dependent effect on cardiac malformation, where stages I, II, and IV were highly 
influenced by exposure to a higher dose of the Ag NPs (0.20 and 0.50 nM).  The 
investigation of biocompatibility of nanomaterials in specific stages of development of 
embryos at single NP level can offer new knowledge about the developmental processes 
and environment, and provide new insights into the mechanics of the developing embryo 
as well as aid in the finding for functional nano-developmental treatments for various 
disorders in early development. 
 In chapter V, we used our purified Ag NPs from chapter IV to study the 
effects of Ag NPs on embryonic neurological development.  More specific, we exposed 
Tg(pax2a:GFP) zebrafish embryos to diluted concentrations of the Ag NPs, studying the 
expression of the pax2a gene during treatment using fluorescent microscopy.  This design 
approach was more practical to study the molecular mechanism of key developmental 
biomarkers that regulate brain development in zebrafish.  Sublethal concentrations of the 
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Ag NPs (0.00, 0.50, 1.00, 2.00, and 5.00 pM) also showed a phenotypical dependent 
morphological effect during development.  However, we did not observe a significant 
decrease in expression of GFP when exposed to Ag NPs.  We observed that a higher 
dose of the Ag NPs leads to severe deformities.  We also demonstrated the effects of Ag 
NPs on cardiac response during exposure.  We observed that Ag NPs can decrease the 
heart rate of both normal and deformed zebrafish.  This study also demonstrated dose-
dependent effects of Ag NPs on eye development, where higher concentrations of the Ag 
NP lead to microphthalmia in developing embryos.  We also designed an in vivo assay to 
study the uptake of Ag NPs in developing embryos.  Here, we observed a significant 
difference in uptake of those embryos that developed abnormally or who did not survive 
during treatment. This study emphasized different in vivo assays that can be explored to 
gain more knowledge on neurological development in zebrafish, which can lead to better 
design or more biocompatible biosensors to explore therapeutic and molecular assays of 
embryogenesis and neurological diseases. 
The results of the research mentioned in this dissertation have demonstrated that 
zebrafish embryos are powerful in vivo model system to use to study the biocompatibility 
and toxicity of metal ions and nanomaterials.  This opens up the possibility of using this 
system as a standard assay to screen many different types of multi-functional NPs, 
including protein-specific nanomaterials that could potentially be used for targeted 
therapeutic applications.  There is the possibility of using NPs in vivo environments as 
effective drug delivery vehicles by attaching desired drug molecules to the surface of NPs.  
For this reason, it is very important to collect preliminary data on how NPs influence 
molecular mechanisms and function of key developmental biomarkers during developing 
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and if these nanomaterials will be toxic to living cells.  To conclude, the chapters included 
in this dissertation have shown conclusively the versatile nature of using zebrafish 
embryos as an in vivo assay to study the effects of silver ions and silver nanoparticles 
during embryonic development.  
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